Cost effectiveness of Daclatasvir/Asunaprevir versus Peginterferon/Ribavirin and protease inhibitors for the treatment of Hepatitis C Genotype 1B in Chile (Englisch)
- Neue Suche nach: Vargas, C.
- Neue Suche nach: Espinoza, M. A.
- Neue Suche nach: Giglio, A.
- Neue Suche nach: Soza, A.
- Neue Suche nach: Vargas, C.
- Neue Suche nach: Espinoza, M. A.
- Neue Suche nach: Giglio, A.
- Neue Suche nach: Soza, A.
In:
VALUE IN HEALTH
;
18
, 3
;
A225-A226
;
2015
-
ISSN:
- Aufsatz (Zeitschrift) / Print
-
Titel:Cost effectiveness of Daclatasvir/Asunaprevir versus Peginterferon/Ribavirin and protease inhibitors for the treatment of Hepatitis C Genotype 1B in Chile
-
Beteiligte:Vargas, C. ( Autor:in ) / Espinoza, M. A. ( Autor:in ) / Giglio, A. ( Autor:in ) / Soza, A. ( Autor:in )
-
Erschienen in:VALUE IN HEALTH ; 18, 3 ; A225-A226
-
Verlag:
- Neue Suche nach: Elsevier Science B.V., Amsterdam
-
Erscheinungsdatum:01.01.2015
-
Format / Umfang:A225-A226
-
ISSN:
-
Medientyp:Aufsatz (Zeitschrift)
-
Format:Print
-
Sprache:Englisch
- Neue Suche nach: 610
- Weitere Informationen zu Dewey Decimal Classification
-
Klassifikation:
DDC: 610 -
Datenquelle:
© Metadata Copyright the British Library Board and other contributors. All rights reserved.
Inhaltsverzeichnis – Band 18, Ausgabe 3
Zeige alle Jahrgänge und Ausgaben
Die Inhaltsverzeichnisse werden automatisch erzeugt und basieren auf den im Index des TIB-Portals verfügbaren Einzelnachweisen der enthaltenen Beiträge. Die Anzeige der Inhaltsverzeichnisse kann daher unvollständig oder lückenhaft sein.
- A1
-
OUTCOMES AND HEALTH RESOURCE UTILIZATION AMONG PATIENTS WITH HEART FAILURE WITH REDUCED EJECTION FRACTION (HFREF) AT AN ACADEMIC MEDICAL CENTER (AMC) IN THE UNITED STATESBress, A. / King, J. / Singhal, M. / Brixner, D. / Kielhorn, A. / Patel, H. / Maya, J. / Biskupiak, J. / Munger, M. et al. | 2015
- A2
-
Differences in Mastectomy Rates Based on Hormone Receptor Status in Early Stage Tumors: A Seer Database AnalysisHinyard, L. / Schwartz, T. et al. | 2015
- A3
-
The Effect Of Cost-Related Medication Nonadherence On The Decision Of Taking Up Medicare Part D Among Elderly Medicare BeneficiariesHan, Y. / Balkrishna, R. et al. | 2015
- A4
-
Economic Value Of Improved Accuracy For Self-Monitoring Of Blood Glucose Devices For Type 1 DiabetesMcQueen, R. / Breton, M. / Ott, M. / Koa, H. / Beamer, B. / Campbell, J. D. et al. | 2015
- A5
-
A Comparative Cost Utility Analysis For First Line Treatment Of Metastatic Non-Small Cell Lung Cancer (Nsclc) Patients With Egfr Exon 19 Deletions Or Exon 21 (L858r) Substitution MutationsCarlson, J. J. / Slejko, J. F. / Goertz, H. / Veenstra, D. L. et al. | 2015
- A6
-
Life At A Premium: Considering An End-Of-Life Premium In Value-Based ReimbursementMcCabe, C. / Paulden, M. / O’Mahony, J. F. / Edlin, R. / Culyer, A. J. et al. | 2015
- A7
-
A Review And Update To The Guidance Document For The Costing Process In The Canadian Health Care SettingBudden, A. J. / Lee, K. / Jacobs, P. et al. | 2015
- A8
-
Systematic Review Of Cost Effectiveness Of Ultra-Orphan Therapies: Lesson Learned From Published Htas And StudiesAggarwal, S. / Topaloglu, H. / Kumar, S. et al. | 2015
- A9
-
Patient Versus General Population Preferences In Anticoagulant TherapyNajafzadeh, M. / Gagne, J. J. / Choudhry, N. K. / Polinski, J. / Avorn, J. L. / Schneeweiss, S. et al. | 2015
- A10
-
Getting The Full Picture: The Importance Of Exrapolating Beyond The DataAl-Mutairi, R. / Rittenhouse, B. et al. | 2015
- A11
-
Usage Of Propensity Score, Instrumental Variable, Or Machine Learning For Real World Data AnalysisChoi, S. et al. | 2015
- A12
-
Combining Mcda With Advanced Statistics To Tackle Challenges Of Data And Judgment Uncertainty: Case Study Of Safety AssessmentsGoetghebeur, M. M. / Wagner, M. / Nikodem, M. / Zyla, A. / Micaleff, A. / Amzal, B. et al. | 2015
- A13
-
Statistical Identification Of Patient Selection Bias In Retrospective Chart ReviewsSignorovitch, J. E. / Reichmann, W. M. / Li, N. / Liu, Z. / Hao, Y. / Perez, J. R. et al. | 2015
- A14
-
Review of cost-effectiveness analyses of varicella vaccination: which model structure assumptions and input parameters matter?Talbird, S. E. / Mauskopf, J. A. / Yang, H. K. et al. | 2015
- A15
-
Suggestion Of New Methods To Calculate Confidence Interval For Incremental Cost-Effectiveness Ratio Which Solve The Issues With Conventional MethodAranishi, T. / Ikeda, S. et al. | 2015
- A16
-
The Cost Of Drug-Related Morbidity That Lead To Emergency Visits In A Brazilian HospitalFreitas, G. / Balbinotto, G. / Hughes, D. / Heineck, I. et al. | 2015
- A17
-
A Virtual Database To Measure Costs Associated With Comorbidities Among Patients With Chronic HcvKawabata, H. / Behl, A. / Hines, P. / Liu, T. / Sill, B. / Hede, S. / Gorsh, B. / Moorthy, V. et al. | 2015
- A18
-
Lack Of Adherence To Immunosuppressive Treatment In Kidney Transplant Patients: Computer Assisted Qualitative Data Analysis (Caqdas) Of An Expert PanelCallejo, D. / Rodríguez-Aguilella, A. / Fernández-Ortiz, L. / González, E. / Toledo, A. / Rebollo, P. / Muduma, G. et al. | 2015
- A19
-
Joint Estimation Of Markov Chain Transition Probabilities Using Survival Models And Constrained Optimization: A Case Study On Diabetes And Mortality And Their Association With Body Mass Index, Age, And GenderWu, S. / Li, J. / Carlsson, N. P. / Leung, M. Y. / Colditz, G. A. / Chang, S. et al. | 2015
- A20
-
Reduction Of Influenza Disease Cost With Suboptimal VaccinationBailey, N. / Wilson, A. / Li, Y. et al. | 2015
- A21
-
Whole-Disease Model Approach: Methodologies And Challenges In Communicating The Economic Burden Of Rare DiseasesShah, A. / Proach, J. et al. | 2015
- A22
-
Contrasting The Relative Risk Reduction Of Cardiovascular Events In The Core Diabetes Model Associated With Single Risk Factor Changes Across Alternative Risk Engines: Ukpds68, Ukpds82 And Swedish National Diabetes Registry EquationsFoos, V. / Lamotte, M. / McEwan, P. et al. | 2015
- A23
-
Development And Validation Of The Hemophilia-Specific Burden Scale For Caregivers Of Children With Hemophilia In The Us – The Hemophilia Associated Caregiver Burden Scale (Hemocabtm)von Mackensen, S. / Wisniewski, T. / Urgo, J. / Boggio, L. et al. | 2015
- A24
-
Does differential framing of opt-out alternatives in discrete choice experiments (dces) matter? Comparison of random utility maximization (rum) and random regret minimization (rrm) modelsChaugule, S. / Hay, J. W. / Young, G. / Martin, O. A. / Drabo, E. F. et al. | 2015
- A25
-
Depression And Quality Of Life Among Individuals With Chronic Obstructive Pulmonary Disease In North IndiaNegi, H. / Raval, A. et al. | 2015
- A26
-
Examining The Relationship Between Health-Related Quality Of Life And Increasing Numbers Of DiseasesRand-Hendriksen, K. / Augestad, L. A. / Whitehurst, D. G. / Barra, M. et al. | 2015
- A27
-
Usability Testing Of The Web-Based Versions Of The Standardised Asthma Quality Of Life Questionnaire For 12 Years And Older (Aqlq(S)+12) And The Asthma Control Questionnaire (Acq-6)Juniper, E. F. / Lambe, J. / Thomas, M. / Arden-Close, E. / Grataloup, G. et al. | 2015
- A28
-
Development Of A Disease Model For Sporadic Inclusion Body Myositis (Sibm)Gnanasakthy, A. / DeMuro, C. / Lewis, S. / Tseng, B. et al. | 2015
- A29
-
Challenges Faced During Linguistic Validation For South AfricaTowns, L. / Williams, H. / Anderson, H. / Gergovich, B. et al. | 2015
- A30
-
Importance Of The Conceptual Definition Of Pro Measures: A Case Study With The Linguistic Validation Of The Irritable Bowel Syndrome Quality Of Life (Ibs-Qol) Instrument In 17 Asiatic LanguagesLambe, J. / Patrick, D. L. / Toraubully, N. / Skerritt, B. / Acquadro, C. et al. | 2015
- A31
-
Alternative Weighting Approaches For Matching Adjusted Indirect Comparisons (Maic)Belger, M. / Brnabic, A. / Kadziola, Z. / Petto, H. / Faries, D. et al. | 2015
- A32
-
Cluster Analysis Of Healthcare Costs Patterns In END STAGE Renal Failure Patients Who Initiated HemodialysisLiao, M. / Li, Y. / Kianifard, F. / Obi, E. / Arcona, S. et al. | 2015
- A33
-
Response Rates In Direct-To-Patient SurveysGoolsby Hunter, A. / Brenneman, S. et al. | 2015
- A34
-
An Analytical Criterion For Judging The Extended Dominancy Of A New Technology Compared To The Standard Of Care And Placebo ControlKamae, I. / Sugimoto, T. / Yamabe, K. et al. | 2015
- A35
-
Advancing Methods Of Hta: Optimising Monitoring Tests To Meet Value TargetsMcCabe, C. / Paulden, M. / Akude, P. et al. | 2015
- A36
-
Data Cleaning Paper Patient Reported Outcome (PRO) Data Versus Electronic Patient Reported Outcome (EPRO) DataRoss, J. / Holzbaur, E. / Wade, M. / Rothrock, T. et al. | 2015
- A37
-
Major and minor adverse events in patients were subjected in Cardiac Rhythm Management Devices (CRMD’s) Therapy and their financial implication: a prospective single-center two years SurveyFanourgiakis, J. A. / Simantirakis, E. / Kanoupakis, E. / Chrysostomakis, S. / Chlouverakis, G. / Vardas, P. et al. | 2015
- A38
-
Time-dependence of first appropriate Therapy in primary prevention implantable cardioverter defibrillator patients: is device replacement necessary in patients without prior ICD interventions?Kanoupakis, E. / Fanourgiakis, J. A. / Kallergis, E. / Mavrakis, H. / Maragoudakis, S. / Vernardos, M. / Chlouverakis, G. / Vardas, P. et al. | 2015
- A39
-
Examination of interval incidence of Colorectal Cancer (CRC) at subsequent colonoscopy over time: population-based retrospective cohort studyRen, J. / Asche, C. V. / Kirkness, C. S. / Puli, S. et al. | 2015
- A40
-
The use of Ultrasonic Energy in mastectomy and Lumpectomy procedures: a budget impact analysisOndrejicka, D. A. / Goldstein, L. J. et al. | 2015
- A41
-
Impact of sample collection method for EGFR mutation testing: results of Blood-based and Tissue-based Cobasâ® EGFR mutation testing in the treatment of locally advanced or metastatic NSCLC in the USPoulios, N. / Hristova-Neeley, D. / Gavaghan, M. et al. | 2015
- A42
-
Economic impact of open mechanical stapling vs. manual suturing in ileocolic anastomosis in Mexican Public Healthcare InstitutionsZanela, O. O. / Cabra, H. A. / Sanchez, D. et al. | 2015
- A43
-
A System dynamics model for the cost-effectiveness evaluation of Bacterial whole-genome sequencing for detecting and monitoring outbreaks of MRSAAgirrezabal, I. / Buchanan-Hughes, A. M. / Eddowes, L. A. / Luheshi, L. M. / Sagoo, G. S. / Török, M. E. et al. | 2015
- A44
-
Cost-effectiveness analysis of External looping recording compared to holter monitoring for Syncope in ColombiaOrozco, J. J. / Shrivastav, M. / Vilendrer, S. et al. | 2015
- A45
-
Cost-utility of repetitive Transcranial Magnetic Stimulation versus Antidepressant Therapy for treatment-resistant depressionGordon, L. G. / Nguyen, K. et al. | 2015
- A46
-
Screening high-risk populations for Latent Tuberculosis: a systematic review of cost-utility analysesCampbell, J. R. / Marra, F. et al. | 2015
- A47
-
Patient’s preferences for dry powder inhaler attributes in Asthma and Chronic Obstructive Pulmonary Disease: a discrete choice experimentHawken, N. A. / Aballéa, S. / Torvinen, S. / Plich, A. / Toumi, M. et al. | 2015
- A48
-
A Framework for coverage decisions for Digital Health TechnologiesWaterman, J. / Taggart, C. / Garfield, S. et al. | 2015
- A49
-
The rise of the value analysis committee at Us Hospitals, better or worse for medical device companies?Hristova-Neeley, D. / Armstrong, S. / Garfield, S. / Ertel, D. et al. | 2015
- A50
-
Effects of Autologous fat grafting systems on inpatient operating room time and costs: a Hospital budget impact analysisLee, L. J. / Xu, S. J. / Mencer, M. / Macarios, D. / Nahabedian, M. Y. et al. | 2015
- A51
-
Hemostasis efficacy of evarresttm compared to Tachosil® in Liver and other Surgical Bleeding: an indirect comparisonCorral, M. / Jamous, N. / Ferko, N. / Bourque, M. et al. | 2015
- A52
-
Comparative outcomes of Testosterone therapy versus no Treatment in hypogonadic menNoone, J. / Blanchette, C. M. / Van Doren, B. A. / Zacherle, E. et al. | 2015
- A53
-
Anti-Diabetic Drugs and the risk of Dementia Among Medicare Beneficiaries with diabetesYuan, J. / Lu, K. et al. | 2015
- A54
-
Real-world canagliflozin utilization: Impact on glycemic control in Patients with Type 2 diabetes mellitusMeckley, L. M. / Miyasato, G. / Kokkotos, F. / Bailey, R. A. et al. | 2015
- A55
-
Metformin and Intensive lifestyle intervention for pre-diabetes - systemati Review of EfficacyFujii, R. K. / Junqueira, M. / Restrepo, M. / Turatti, L. A. et al. | 2015
- A56
-
Efficacy And Safety of Canagliflozin among Patients with type 2 diabetes Mellitus: a Systematic review and meta-analysisKaur, K. / Likhar, N. / Dang, A. et al. | 2015
- A57
-
Temporal Trend and Prevalence of Ckd Stages (Kdigo 2012) in Us Adults with Type 2 Diabetes Mellitus and demographic Subgroups: Nhanes 2007-2012Wu, B. / Bell, K. / Kern, D. M. / Tunceli, O. / Willey, V. / Vupputuri, S. / Stanford, A. / Kalsekar, I. et al. | 2015
- A58
-
Modeling the Long Term Economic Benefits of a Patient-Adjusted Mealtime Insulin Titration Algorithm among Patients with Type 2 diabetes in the united StatesNumapau, N. O. / Murphy, D. R. / Curtis, B. H. / Gahn, J. C. / Curtis, S. / Perk, S. / Yu, X. / Smolen, H. J. et al. | 2015
- A59
-
Estimating Clinical and Economic Outcomes Following a Diabetes-Related vascular ComplicationPerk, S. / Murphy, D. R. / Gahn, J. C. / Yu, X. / Smolen, H. J. et al. | 2015
- A60
-
Diabetes Mellitus Treatment: Cost-Effectiveness of Schemes Therapeutic Glargine and Nph - Brazil, 2014Alvares, J. / Almeida, A. M. / Faleiros, D. / Araujo, V. E. / Guerra Junior, A. A. / Acurcio, F. d. et al. | 2015
- A61
-
Cost-effectiveness Analysis of second-Line and third-Line antidiabetic Drugs In Tyep 2 Diabetes: an Empirical, population-based observational Study From TaiwanOu, H. T. / Balkrishnan, R. / Yang, C. Y. / Chang, K. C. et al. | 2015
- A62
-
The Cost-effectiveness of canagliflozin (Cana) versus Saxagliptin (Saxa) among older Individuals living with type 2 diabetes mellitus (T2dm) In canadaTeschemaker, A. / Neslusan, C. / Sabapathy, S. / Yoong, K. / Johansen, P. / Willis, M. et al. | 2015
- A63
-
Impact of a Pharmacist telephone Intervention on Preventing Medication discontinuation among Hypertensive Patients With Diabetes In a Medicare advantage planWang, X. / Serna, O. / Henges, C. / Essien, E. J. / Chung, N. / Fleming, M. / Abughosh, S. et al. | 2015
- A64
-
Validation of Prescription Medication Adherence prediction Tool (Rxapt) to Predict non-Adherence among Diabetes Patients Enrolled in medicareMhatre, S. / Sansgiry, S. / Serna, O. et al. | 2015
- A65
-
Engaging Patients With E-Clinical Technology: Incorporating Patient Preferences Into Diabetes Clinical Trials And CareKhurana, L. / Gary, S. T. / Vazquez, V. / Otero, A. / Evans, C. / Dallabrida, S. et al. | 2015
- A66
-
Growth Hormone deficiency in Pediatrics: Concept Elicitation To Support The Development of Child Pro And Parent Obsro MeasuresBrod, M. / Håkan-Bloch, J. / Hojbjerre, L. / Alolga, S. L. / Nacson, A. / Rasmussen, M. H. et al. | 2015
- A67
-
Depression Treatment and Health-Related quality of Life among adults with Diabetes and depressionAlenzi, E. / Sambamoorthi, U. et al. | 2015
- A68
-
Comparative Persistency with Newer agents used to Treat Type 2 Diabetes (T2dm) In the united states: canagliflozin Versus Dipeptidyl Peptidase-4 (Dpp-4) Inhibitors and Glucagon-Like Peptide-1 (Glp-1) agonistsDiels, J. / Neslusan, C. et al. | 2015
- A69
-
Financing a Cure for Diabetes In a multi-Payer environmentBasu, A. / Kamal-Bahl, S. / Subedi, P. et al. | 2015
- A70
-
Changes In Baseline Comorbidities, Medications And Healthcare Costs for A Population of Patients With New-Onset Type 2 Diabetes (T2d) In 2007 Compared With 2012Weng, W. / Liang, M. / Kimball, E. / Hobbs, T. / Kong, S. / Bouchard, J. / Sakurada, B. et al. | 2015
- A71
-
Preparation of a dataset for analysis to develop a predictor Algorithm for Disease State ManagementLovett, A. W. / Chaturvedula, A. / Mukherjee, K. / Brar, A. / Tamhankar, N. et al. | 2015
- A72
-
The impact of the essential Medicine policy on patients’ Health Care Utilization and cost in Tianjin China: a quasi-experimental DesignDing, L. / Wu, J. et al. | 2015
- A73
-
Analysis of the Drug price reviews performed by the Canadian Patented Medicine Prices review Board (1998-2014)Alsumali, A. / Seoane-Vazquez, E. / Eguale, T. / Mekary, R. et al. | 2015
- A74
-
Orphan and Ultra-Orphan Technologies in the new era of payment reform: United States payer perceptionsHogue, S. / Brogan, A. P. / Croft, E. et al. | 2015
- A75
-
FDA breakthrough Therapy status - a systematic analysis of all Therapies approved under this new expedited Approval PathwayMacaulay, R. et al. | 2015
- A76
-
Developing Algorithms for identifying beneficiaries with higher than expected Utilization of opioids AnalgesicsVerma, D. / Banahan, I. B. / Hardwick, S. P. / Clark, J. P. et al. | 2015
- A77
-
Drug related problems, prescribing pattern and Polypharmacy: evidence from Community Pharmacies in PakistanIqbal, M. S. / Iqbal, M. Z. / Iqbal, M. W. / Akhtar, N. / Bahari, M. B. et al. | 2015
- A78
-
Acountable care Organizations- an Economic solution to provide Quality Healthcare for Medicare PatientsPatel, P. H. et al. | 2015
- A79
-
Impact of cost sharing increases under part D specialty tiers on Biologic adherence and discontinuation among Medicare Beneficiaries with multiple Sclerosis or Rheumatoid ArthritisLi, P. / Hu, T. / Yu, X. / Chahin, S. / Dahodwala, N. A. / Doshi, J. A. et al. | 2015
- A80
-
The Californian Technology assessment forum – the arrival of cost-utility appraisals of Drugs in the USA?Macaulay, R. / Mistry, J. et al. | 2015
- A81
-
Economic impact of waste in Prescribing, Dispensing, and Medication consumption in the United StatesAlmanie, S. A. / Holdford, D. A. et al. | 2015
- A82
-
Impact of the shift to Medicaid managed care on resource Utilization and costs for beneficiaries in Mississippi MedicaidRamachandran, S. / Banahan, I. B. / Hardwick, S. P. / Clark, J. P. et al. | 2015
- A83
-
Cross section analysis of Marginal NHS expenditure by England Health areaHernandez-Villafuerte, K. / Sussex, J. et al. | 2015
- A84
-
Improved Heor writing skills of keen interest to Bio/Pharma Heor Directors and ManagersDrake, T. / Peeples, P. / Smalarz, A. / McClain, B. et al. | 2015
- A85
-
Use of low-cost Generic Programs in a Nationally representative Medicare Population and implications for Quality initiativesPauly, N. / Brown, J. et al. | 2015
- A86
-
An intensive study of adverse events in the Medical Unit of a Nigerian Teaching HospitalOreagba, I. A. / Bada, S. O. / Chuka-Ebene, V. et al. | 2015
- A87
-
The value of otc Medicines in Brazilian Public Health System (SUS)Ferreira, C. N. / Santana, C. F. / Rufino, C. S. et al. | 2015
- A88
-
The effect of Innovation lag on Drug access in TaiwanHsieh, C. / Tasi, Y. / Chiang, Y. / Huang, W. et al. | 2015
- A89
-
A Survey of ispor attendee views on the use of ICER and acceptable ICER thresholdsKaura, S. / Seetasith, A. / Ramesh, V. / Nanavaty, M. / Proach, J. / Khan, Z. M. et al. | 2015
- A90
-
Gender differences in the use of Complementary and Alternative Medicine among Adults with Multiple Chronic conditionsAlwhaibi, M. / Sambamoorthi, U. et al. | 2015
- A91
-
Pharmacy Directors’ perceptions of Administrators’ and Health Professionals’ attitudes towards Collaborative Drug Therapy Management (CDTM) in U.S. hospitalsMishra, P. / Thomas, I. J. et al. | 2015
- A92
-
Perceptions and Knowledge on Antibiotic use and resistance among High School Students and Teachers in New Delhi, IndiaKotwani, A. / Wattal, C. / Siddiqui, Z. / Joshi, P. et al. | 2015
- A93
-
Trend analysis of SMC decisions – what factors influence the likelihood of positive, restricted and negative recommendations?Hill, D. / Marshall, J. D. / Hill, C. A. / Harries, M. et al. | 2015
- A94
-
Trends in Health Technology Assessment (HTA) recommendations from the UK and Germany – a comparison of G-BA, SMC and NICE single Technology appraisal decisionsHill, C. A. / Hill, D. / Marshall, J. D. / Harries, M. et al. | 2015
- A95
-
A Comparison of G-BA’s additional benefit score to NICE ICERsJaksa, A. / Liden, D. / Ho, Y. et al. | 2015
- A96
-
Comparison Of Health Technology Assessment (Hta) Rankings By German And French Hta AgenciesHu, I. / Zheng, J. / Hu, X. H. et al. | 2015
- A97
-
Multiple Chronic Conditions And Bmi: Population Estimates For Health Decision Making In Puerto RicoAmill, A. / Serrano, R. / González, E. / Pérez-Perdomo, R. et al. | 2015
- A98
-
Evaluation Of Knowledge, Attitudes, And Practices Of Healthcare Providers Towards Nutrition Support In PakistanIqbal, M. S. / Bahari, M. B. / Iqbal, M. Z. / Iqbal, M. W. / Nasir, S. et al. | 2015
- A99
-
Irrational drug use pattern in hospitals. A warning for health care systemUmer Jan, S. et al. | 2015
- A100
-
Two-Part Pricing For Patent Protected Medicines †“An Economic Analysis From A Swedish Health Care PerspectiveHertzman, P. G. / Holm, J. et al. | 2015
- A101
-
Comparison Of Machine Learning, Statistical And Hybrid Methods To Identify Predictors Of Positive Treatment Outcomes In Comorbid Conditions Using Emr DataLipkovich, I. / Griner, B. P. / Niemira, J. / Jin, C. et al. | 2015
- A102
-
Augmenting The Regulatory Requirements Of Medication Therapy Management To Improve Program Efficiency And OutcomesMbagwu, G. / Godley, P. et al. | 2015
- A103
-
comparing Medical Therapies For Heavy Menstrual Bleeding Related To Uterine FibroidsYao, X. / Stewart, E. / Laughlin-Tommaso, S. / Borah, B. / Heien, H. et al. | 2015
- A104
-
Factors Affecting Parents’ Knowledge And Practice About Childhood Immunization: Experience From MalaysiaAwadh, A. / Hassali, M. / Al-lela, O. / Bux, S. et al. | 2015
- A105
-
Administration Cost Of Pediatric Vaccination: A Focused Literature ReviewMokiou, S. / de Cock, E. et al. | 2015
- A106
-
Implications Of Employer Coverage Of Contraception: Cost-Effectiveness Of Contraception Under An Employer MandateCanestaro, W. / Vodicka, E. / Downing, D. et al. | 2015
- A107
-
A Systematic Review Of The Use Of The Time Preference Model To Explore Medication Adherence BehaviorMezgebe, M. / Lovett, A. et al. | 2015
- A108
-
Describing Medication Adherence Across A Population: The Value Of Considering Multiple MeasuresAguilar, K. / Hou, Q. / Miller, R. et al. | 2015
- A109
-
Prevalence And Losses In Quality-Adjusted Life Years Of Child Health Conditions: A Burden Of Disease AnalysisCraig, B. / Hartman, J. / Owens, M. / Brown, D. et al. | 2015
- A110
-
Analysis Of Survey Data For Learning Effectiveness Evaluation Of A Talent Management Program For Dairies And FeedlotsBouwer, A. et al. | 2015
- A111
-
A Conceptual Framework For Translating Patient-Reported Outcomes For Implementation In Clinical Practice And Quality Improvement EffortsJeswani, N. / Gaur, P. / Ganesan, N. / Mitchell, K. et al. | 2015
- A112
-
Impact Of Pediatric Regulation On Availability Of Neonate Drug InformationLindberg-Springs, S. / Nambiar, S. / Seoane-Vazquez, E. et al. | 2015
- A113
-
Evaluation Of The Potential Impact Of Drug-Gene Interaction Risk (Dgir) On Health Resource Utilization (Hru)Bress, A. / Unni, S. / Biltaji, E. / Sass, R. / Mamiya, T. / Ye, X. / Yu, B. / Biskupiak, J. / Brixner, D. et al. | 2015
- A114
-
Anticholinergic Medication use and risk of incident Fractures in the elderly with DepressionChatterjee, S. / Aparasu, R. / Carnahan, R. / Chen, H. / Johnson, M. L. et al. | 2015
- A115
-
Antipsychotics for treatment of Pediatric Schizophrenia: a systematic review and network meta-analysis of Symptom control, Weight Gain and discontinuation due to adverse eventsHarvey, R. C. / Shields, G. E. / James, A. C. et al. | 2015
- A116
-
Examining prevalence, incidence and mortality rates among opioid-dependent patients in the U.S. Medicare PopulationLi, L. / Shrestha, S. / Baser, O. / Yuce, H. / Wang, L. et al. | 2015
- A117
-
Socioeconomic status and Depression in JapanTakahashi, O. / Ohde, S. / Deshpande, G. et al. | 2015
- A118
-
Healthcare resource Utilization and costs associated with Paliperidone Palmitate versus oral Atypical Antipsychotics among patients with Schizoaffective DisorderPesa, J. A. / Muser, E. / Montejano, L. B. / Kim, G. / Smith, D. M. et al. | 2015
- A119
-
Healthcare resource Utilization and costs for Schizophrenia Patients initiating asenapine or another branded- atypical Antipsychotic MedicationNguyen, K. / Chitnis, A. / Sun, S. X. / Dixit, S. / Wang, R. / Tawah, A. / Boulanger, L. et al. | 2015
- A120
-
Cost effectiveness analysis of different treatment alternatives in Children with attention deficit hyper activity Disorder (ADHD)El-Hamamsy, M. / Elsayed, B. M. / Eid, E. M. et al. | 2015
- A121
-
Cost-utility of Vortioxetine versus Venlafaxine xr in the treatment of Major depressive Disorder in South KoreaJung, R. / Brignone, M. / Campbell, R. / François, C. / Milea, D. et al. | 2015
- A122
-
Caregivers’ preferences for treatment options in Attention Deficit Hyperactivity Disorder (ADHD): a latent class analysisNg, X. / Bridges, J. F. / Ross, M. M. / Frosch, E. J. / Reeves, G. M. / dosReis, S. et al. | 2015
- A123
-
Factors affecting Health-related Quality of life in individuals with DepressionShah, D. / Anupindi, V. R. / Vaidya, V. / Goodman, M. et al. | 2015
- A124
-
Metareview of findings in Existing Literature reviews covering Behavioral Health-Physical Health Integration StudiesKeleti, D. / Golinkoff, M. / Weaver, K. / Michael, K. E. / Gelzer, A. D. et al. | 2015
- A125
-
Audit of irreversible Monoamine Oxidase Inhibitors (MAOI) prescription for depression in current Clinical practice within the Health improvement Network (THIN) UK primary care databaseO’Leary, C. J. / Nasser, A. / Myland, M. / Waples, S. / Ansell, D. et al. | 2015
- A126
-
Health resource use of Patients enrolled to Janssen connect treated with Long-Acting Injectable (LAI) atypical Antipsychotics: preliminary results from a summative EvaluationBenson, C. / Boulanger, L. / Yang, E. / Pan, X. / Payne, K. / Fastenau, J. et al. | 2015
- A127
-
Use of Clozapine and Antipsychotic Polypharmacy among patients with Schizophrenia: characterizing the prescribersTang, Y. / Horvitz-Lennon, M. / Gellad, W. F. / Normand, S. T. / Donohue, J. M. et al. | 2015
- A128
-
Physician care-providing Behavior in treating Attention-Deficit Hyperactive Children and AdolescentsPatel, A. / Chen, H. / Aparasu, R. / Ochoa-Perez, M. / Chan, W. / Sherer, J. et al. | 2015
- A129
-
A Study of Adverse Drug Reactions Associated With Antihypertensive Agents In A Tertiary Care Teaching Hospital In Central NepalPaudel, S. / Subedi, N. et al. | 2015
- A130
-
Validation Of Hypertensive Patient Identification And Effect Of Varying Observation Time From Administrative Claims Data Using Electronic Medical RecordsLiu, J. / Ma, Q. / Rodenberger, D. / Barron, J. et al. | 2015
- A131
-
Ehealth In The Management Of Chronic Diseases: A Review Of Program EfficacyKiss, N. / Fortier, K. et al. | 2015
- A132
-
The Use Of Low Molecular Weight Heparin And Pneumatic Compression Devises For Deep Vein Thrombosis Prophylaxis In Major Trauma Patients: A Comparative Effectiveness AnalysisAlahmari, A. K. / Almalki, Z. S. / Guo, J. J. et al. | 2015
- A133
-
Evaluation Of Bleeding Outcomes Linked To New Oral Anticoagulants: Review Of The Fda Adverse Event Reporting System (Faers)Jacobs, D. M. / Hempel, C. / Feuerstein, S. et al. | 2015
- A134
-
Physician’s Adherence To Treatment Guidelines In Deep Vein Thrombosis At An Indian Tertiary Healthcare FacilityTiwari, P. / Sunarikani, R. / Malhotra, S. et al. | 2015
- A135
-
Geographic Differences In Availability Of Antihypertensive Medications: A Comparison Of Australia, Canada, Saudi Arabia, Uk, And The UsAlmutairi, H. / Alzarea, A. I. / Seoane-Vazquez, E. / Mekary, R. et al. | 2015
- A136
-
Examining Association Between Liver Enzymes And Lipid Levels Amongst Adults In The United States: A Cross Sectional StudySakharkar, P. / Deb, S. et al. | 2015
- A137
-
Expected Cost Of Drug Therapy In Patients With Arterial Hypertension, Diabetes Mellitus And Dyslipidemia In Chile: A Probabilistic AnalysiSBalmaceda, C. / Espinoza, M. A. et al. | 2015
- A138
-
Acute, Short-Term And Long-Term Costs Of Cardiovascular Events Among Hyperlipidemia PatientsPaoli, C. J. / Gandra, S. R. / Henk, H. J. et al. | 2015
- A139
-
Long-Term Economic Burden Associated With Cardiovascular Events Among High-Risk Patients With HyperlipidemiaFox, K. M. / Wang, L. / Gandra, S. R. / Quek, R. G. / Li, L. / Baser, O. et al. | 2015
- A140
-
Cost-Efectiveness Of Dabigatran In Non Valvular Atrial Fibrillation In ColombiaTriana, J. J. / Castañeda-Cardona, C. / Parada, L. / Rosselli, D. et al. | 2015
- A141
-
Comparative Cost-Effectiveness Analysis Of Catheter Directed Thrombolisys With Urokinase And Alteplase For Treatment Of Acute Peripheral Artery DiseaseKostyuk, A. / Akanov, A. / Almadiyeva, A. et al. | 2015
- A142
-
The Cost-Effectiveness of Dabigatran Etexilate Compared With Edoxaban In The Treatment of Acute Venous Thromboembolism In The UkJugrin, A. V. / Ustyugova, A. V. / Lamotte, M. / Sunderland, T. J. et al. | 2015
- A143
-
Real-World Outcomes of Acute Ischemic Stroke Patients In The Medicare PopulationWatson, C. / Burudpakdee, C. / Noone, J. / Seetasith, A. / Nyandege, A. et al. | 2015
- A144
-
Health Utilities Of Hypertensive Patients In VietnamNguyen, T. P. / C.C.M., S. / Postma, M. J. et al. | 2015
- A145
-
Patients In The Waiting List Of Bariatric Surgery In The Brazilian Public Sector Treatment Patterns And Health Outcomes: A Non-Interventional Single-Site Retrospective StudyJunqueira Junior, S. M. / Luque, A. / Cabra, H. A. / Andrade, P. C. / Oliveira, F. M. / Brasil, N. / Rasera, I. et al. | 2015
- A146
-
Agents Acting On Renin-Angiotensin System Usage In Croatia During The Fourteen-Year Period: Impact Of GenericsVitezic, D. / Kucan, M. / Mrsic Pelcic, J. / Vitezic, M. et al. | 2015
- A147
-
Influence Of Cost Sharing Differentials On Therapeutic Substitution And Medication Adherence: The Story Of Statins In 2006Li, P. / Schwartz, S. J. / Doshi, J. A. et al. | 2015
- A148
-
Annual Hospitalization Frequency For Patients With Heart Failure - A Comparison Between Commercial And Medicare Advantage PopulationPatel, H. / Maya, J. / Song, R. / Henk, H. J. / Kielhorn, A. et al. | 2015
- A149
-
The Burden Of Uncertainty In Emergency Room: The Case Of Chest PainAbbass, I. M. / Nassar, A. et al. | 2015
- A150
-
Pharmacoeconomics Research On Diabetes And Hypertension In India: A Study Based On Pubmed DatabaseDharmagadda, S. / Vooradi, S. / Mateti, U. V. et al. | 2015
- A151
-
Patterns of treatment modifications in newly treated hypertensive patients: does choice of modification strategy affect likelihood of treatment discontinuation?Sonawane, K. B. / Qian, J. / Garza, K. B. / Wright, B. M. / Zeng, P. / Ganduglia Cazaban, C. M. / Hansen, R. A. et al. | 2015
- A152
-
Safety of Tofacitinib Compared to Biological Dmards In Rheumatoid Arthritis Patients With An Inadequate Response to Methotrexate: overview of Systematic ReviewsReyes, J. M. / Rodriguez, A. et al. | 2015
- A153
-
Incidence and Prognostic Factors for Contralateral Hip Fracture Among Hungarian Men over 60 YearsJuhász, K. / Gajdácsi, J. / Boncz, I. / Molics, B. / Sebestyén, A. et al. | 2015
- A154
-
Comparison of Disease Status and Outcomes of Patients With Rheumatoid Arthritis (Ra) Receiving Adalimumab or Etanercept Monotherapy In The United States (Us)Narayanan, S. / Lu, Y. / Hutchings, R. / Baynton, E. et al. | 2015
- A155
-
Use of Anti-osteoporosis Medications and Fracture Risk Among Elderly Patients With End-Stage Renal Disease: A Retrospective Cohort StudyLo, P. / Tsai, H. / Chao, C. / Peng, L. / Tsai, Y. / Chen, L. et al. | 2015
- A156
-
Relationship Of Sedentary Behavior With Qalys In Community Dwelling Adults With or At Risk for Knee OsteoarthritisPinto, D. / Song, J. / Chang, R. W. / Semanik, P. A. / Ehrlich-Jones, L. / Pellegrini, C. A. / Dunlop, D. D. et al. | 2015
- A157
-
Modeling of Societal Costs Under Different Treatment Schemes of Post-Stroke Spasticity In The Russian FederationYagudina, R. / Kulikov, A. / Ugrekhelidze, D. et al. | 2015
- A158
-
Costs Description of Rheumatoid Arthritis Treatment In Chile For Patients Who Have Failed To Conventional Synthetic DmardsDe la Puente, A. C. / Zaror, S. C. / Velasquez, Z. M. / Bustos Medina, L. / Gutierrez-Ardila, M. V. et al. | 2015
- A159
-
Patient Comorbdity Status And Incremental Total Hospitalization Costs In Elective Orthopedic ProceduresNichols, C. I. / Vose, J. G. et al. | 2015
- A160
-
The Economic Value of Tofacitinib 5 Mg Bid In The Treatment of Moderate To Severe Rheumatoid Arthritis: A Canadian AnalysisWoolcott, J. C. / Blackhouse, G. / Claxton, L. / Wallenstein, G. / Tran, T. / Goeree, R. / Taylor, M. / Moynagh, D. / Singh, A. et al. | 2015
- A161
-
What Is The Cost-Effective Bearing Surface Choice In Primary Total Hip ArthroplastyCarnes, K. J. / Odum, S. M. / Troyer, J. L. / Fehring, T. K. et al. | 2015
- A162
-
Cost-Effectiveness Analysis of Bisphosphonates for Secondary Prevention of Hip Fracture In TaiwanLo, P. / Wen, Y. / Tsai, Y. et al. | 2015
- A163
-
Impact of Rheumatoid Arthritis on Self-Reported Work Productivity, Disease Severity And Adherence In an Employed PopulationKamal, K. M. / Ghosh, S. / Koerner, P. / Miller, R. / Parekh, M. H. / Khairnar, R. et al. | 2015
- A164
-
Preferences for New Treatments Diminish In The Face of AmbiguityHarrison, M. / Bansback, N. et al. | 2015
- A165
-
Minimally Important Differences for Patient-Reported Outcomes Measurement Information System (Promis) Fatigue and Pain Interference ScoresBeaumont, J. L. / Fries, J. F. / Curtis, J. R. / Cella, D. / Yun, H. et al. | 2015
- A166
-
Patient, Health Plan And Community Factors Associated With Receipt of Disease-Modifying Antirheumatic Drugs Among Patients With Rheumatoid Arthritis In Medicare Managed Care PlansMehta, S. / Teigland, C. / Pulungan, Z. / Kilgore, K. / Parente, A. / McClellan, M. / Jones, B. et al. | 2015
- A167
-
Comparison of Clinical Characteristics of Patients With Rheumatoid Arthritis (RA) Identified By Physicians As Potentially Suitable For Biosimilar Infliximab Versus Those Who Were Not Considered Biosimilar Infliximab Suitable In Europe (EU)Narayanan, S. / Lu, Y. / Hutchings, R. / Baskett, A. / Mentzer, S. et al. | 2015
- A168
-
Canadian Public Reimbursement of Subsequent Entry Biologics (Sebs) / BiosimilarsSiu, E. C. / Wyatt, G. et al. | 2015
- A169
-
Mortality And Readmission In Mechanically Ventilated Patients With PneumoniaHansen, R. N. / Black, D. J. / Joish, V. N. / Spilsbury-Cantalupo, M. / Sullivan, S. D. et al. | 2015
- A170
-
Real-World Observational Study of Association Between Statin Medications and Copd-Specific OutcomesAjmera, M. R. / Sambamoorthi, U. / Rust, G. / Pan, X. / Tworek, C. / Metzger, A. et al. | 2015
- A171
-
Factors Affecting 30-Day Hospital Readmissions Among Patients With Chronic Obstructive Pulmonary Disease (Copd)Kim, M. / Asche, C. V. / Tillis, W. et al. | 2015
- A172
-
Health-care costs of asthma are lower using mp29-02* vs. Sequential sprays for allergic rhinitisHarrow, B. / Sedaghat, A. R. / Munzel, U. / Tarr, A. / Gever, L. / Hofmeister, J. / Dufour, R. et al. | 2015
- A173
-
Cost-Effectiveness of Tiotropium Vs Glycopyrronium In Moderate To Very Severe Copd In Canada, Sweden And The UkEklund, O. / Afzal, F. / Borgström, F. / Flavin, J. / Ternouth, A. / Baldwin, M. et al. | 2015
- A174
-
Assure-Csu Canadian Results: Assessing The Impact Of Chronic Spontaneous /Idiopathic Urticaria On Work Productivity And Indirect CostsSussman, G. / Lee, J. / Chiva-Razavi, S. / Chambenoit, O. / Hollis, K. / McBride, D. / Westlund, R. / Tian, H. / Balp, M. et al. | 2015
- A175
-
Treatment outcomes of Smear Positive Pulmonary TB Cases Registered In TB Patients In Quettaul Haq, N. / Baloch, W. / Iqbal, Q. / Naseem, A. / Bashir, S. et al. | 2015
- A176
-
Influence of Demographic Status on Outcomes In Copd Patients: A Prospective StudyA, S. / MK, U. / Mohan, M. K. / Rao, C. M. et al. | 2015
- A177
-
Adherence to Chronic Obstructive Pulmonary Disease Maintenance Medication Among Patients With CopdZhang, S. et al. | 2015
- A178
-
Rate of adverse event-related treatment changes and Healthcare costs associated with topical Rosacea treatmentWilliamson, T. / Kamalakar, R. / Ogbonnaya, A. / Kish, J. / Zagadailov, E. A. / Eaddy, M. / Kreilick, C. et al. | 2015
- A179
-
Study of Psychological stress and ACNE vulgaris among Pharmacy StudentsAb Hadi, H. / Awadh, A. et al. | 2015
- A180
-
Estimating the prevalence of Equine Recurrent Uveitis and the associated loss of value from visual impairment in Horses in the United StatesPoulsen Nautrup, B. / Van Vlaenderen, I. / Holland, R. / Donecker, J. M. et al. | 2015
- A181
-
Cost-effectiveness of Aflibercept in the treatment of Central Retinal Vein Occlusion in TurkeyTunalioglu, A. / Ozdemir, O. / Eldem, B. / Unlu, N. / Alp, M. N. / Saatci, A. O. / Ozmert, E. / Deger, C. / Asan, S. / Sumer, F. et al. | 2015
- A182
-
Economics in clinical guidelines: a cost-effectiveness analysis of repositioning strategies for the prevention of pressure UlcersMarsden, G. / Jones, K. / Neilson, J. / Stansby, G. / Collier, M. / Avital, L. et al. | 2015
- A183
-
Measuring Disease specific impact and symptoms among patients with Hidradenitis SuppurativaKimball, A. / Sundaram, M. / Mathias, A. / Foley, C. / Shields, A. et al. | 2015
- A184
-
Content development and refinement for a new Patient reported outcome measure for Psoriasis Treatment (PROMPT)Kitchen, H. / Cordingley, L. / Young, H. / Griffiths, C. E. / Bundy, C. et al. | 2015
- A185
-
Utilization, Price, and spending trends for Fluoroquinolones in the us Medicaid Program: 1991-2013Yue, X. / Guo, J. J. / Xia, Y. / Almalki, Z. S. / Wigle, P. R. et al. | 2015
- A186
-
The Budget Impact of Treatment Pathway Redesign In Men With Lower Urinary Tract Symptoms (Luts) Associated With Benign Prostatic Hyperplasia (Bph)Patel, S. / Garnham, A. / Nazir, J. et al. | 2015
- A187
-
Cost Of Illness And The Factors Affecting It In The Patients Of Chronic Kidney Disease At A Public Tertiary Care HospitalAhlawat, R. / Tiwari, P. / D’Cruz, S. et al. | 2015
- A188
-
Evaluation Of Medication Adherence Rate Among Hemodialysis Patients: A Multicentric Comparative StudyMateti, U. / Nagappa, A. / Atturi, R. et al. | 2015
- A189
-
Prioritization of Comparative Effectiveness Research Questions Based On Identification of The Most Relevant Outcomes To Improve Clinical Practice: An Application of Mcda To Dialysis Research PlanningKhoury, H. / Nesrallah, G. / Goetghebeur, M. et al. | 2015
- A190
-
Racial/Ethnicity Disparities In The Association Between Diabetes And Pancreatic Cancer In The Elderly Medicare PopulationLu, K. / Yuan, J. / Li, M. / Wu, J. et al. | 2015
- A191
-
The Burden of Aml Within theTurbeville, S. / Francis, K. M. / Behm, I. / Chiu, G. R. / Sanchez, H. / Morgan, J. / Yakovich, A. / Ward, R. / Hyare, P. et al. | 2015
- A192
-
Comparing The Efficacy Of Denosumab Versus Zoledronic Acid (Za) For Prevention Of Skeletal-Related Events (Sres): A Critical Appraisal Of Three Pivotal TrialsStrite, S. / Stuart, M. E. / Beckman, V. / Öhrling, K. et al. | 2015
- A193
-
Incidence And Prevalence Of Basal Cell Carcinoma In A Large United States Commercially Insured PopulationGoldenberg, G. / Karagiannis, T. S. / Palmer, J. B. / Lotya, J. / O’Neill, C. B. / Kisa, R. M. / Herrera, V. et al. | 2015
- A194
-
Overall survival in post-menopausal women with hr+/her2- metastatic breast cancer treated with 1st-line endocrine therapy vs. ChemotherapyVekeman, F. / Hao, Y. / Cheng, W. Y. / Fortier, J. / Robitaille, M. / Duh, M. S. et al. | 2015
- A195
-
Economic Impact of The Addition of Axitinib as a Second Line Treatment for Metastatic Renal cell Carcinoma in the Ecuatorian Public Heathcare SectorRosado-Buzzo, A. / Albuja, M. / Garcia-Molliendo, L. / Luna-Casas, G. et al. | 2015
- A196
-
Treatment Patterns and Costs Associated With Sunitinib and Pazopanib Treatment for Renal Cell Carcinoma: a Commercial Health Claims AnalysisHarnett, J. / MacLean, E. / Bhattacharyya, H. / Cisar, L. / Hoang, C. J. / Mardekian, J. et al. | 2015
- A197
-
Healthcare Resource utilization and Medical Care Cost Associated With New Bio-Surgical Hemostasis In ChinaMa, Y. / Gu, X. / Wu, J. / Yue, N. / Lyu, R. et al. | 2015
- A198
-
Systematic Review of Epidemiology and Burden of Pancreatic CancerAggarwal, S. / Topaloglu, H. / Kumar, S. et al. | 2015
- A199
-
Direct Medical Costs Of Her2 Positive Breast Cancer Management In Iran: A Claims Database And Data Mining AnalysisAnsaripour, A. / Zendehdel, K. / Uyl - de Groot, C. A. / NaemiSanatdost, A. / Redekop, W. K. et al. | 2015
- A200
-
Perceptions Of Biosimilar Monoclonal Antibodies Amongst Eu5 Budget HoldersGardiner, R. B. et al. | 2015
- A201
-
Cost – Efficacy Study for Ipilimumab in the Chilean MarketRovegno, M. / Llanos, C. / Galleguillos, S. / Garrido Lecca, S. et al. | 2015
- A202
-
Cost-Effectiveness Analysis of Female Human Papillomavirus Vaccination In Mainland ChinaGai, R. et al. | 2015
- A203
-
Cost-Effectiveness of Sorafenib for Treatment of Radioactive Iodine (Rai)-Refractory Locally Advanced/Metastatic Differentiated Thyroid Cancer (Dtc) In TurkeyErdal, E. / Sayman, H. / Turkmen, C. / Aral, F. / Yildiz, O. / Okutur, K. / Parali, E. / Deger, C. / Tunalioglu, A. / Sar, C. et al. | 2015
- A204
-
Cost-Effectiveness Of Multiplexed Predictive Biomarker Screening In Non-Small Cell Lung CancerRomanus, D. / Cardarella, S. / Cutler, D. / Landrum, M. B. / Lindeman, N. / Gazelle, G. S. et al. | 2015
- A205
-
Economic Evaluation of Transarterial Chemoembolization With Lipiodol Versus Drug Eluting Bead for the Treatment of Hepatocellular Carcinoma In Egyptian PatientsFouad, S. / Elsisi, G. / Elmahdawy, M. et al. | 2015
- A206
-
Hospital Utilization In Patients With Mantle Cell LymphomaBelk, K. / Craver, C. W. et al. | 2015
- A207
-
The Effectiveness of Carepak® Adherence Packaging In Increasing Lenalidomide Therapy DurationRice, G. / Nolan, R. / Grigorian, M. et al. | 2015
- A208
-
Using Fact Data to Predict Preference-Based Utility Measures For People With Malignant Melanoma: A Review of The EvidenceAra, R. / Paisley, S. / Robinson, A. A. / Azough, A. / Mensah, L. et al. | 2015
- A209
-
Inclusion of Patient-Reported Outcome Measures In Registered Clinical Trials: Evidence From Clinicaltrials.Gov (2007-2013)Vodicka, E. / Kim, K. / Devine, B. / Gnanasakthy, A. / Scoggins, J. / Patrick, D. L. et al. | 2015
- A210
-
Does the generic cancer outcome measure eortc qlq-c30 work in myelofibrosis?Mukuria, C. / Brazier, J. / Rafia, R. et al. | 2015
- A211
-
Quality of Life Domains Associated With ReadmissionHayran, M. / Yüce, D. / Hüseyin, B. / Esin, E. / Kilickap, S. / Erman, M. / Celik, I. et al. | 2015
- A212
-
Are biomarkers a big market access bonus? us and eu5 payer perspectives and prescribing patterns for key targeted non-small-cell lung cancer agentsCox, J. / Roberts, D. / Gheorghe, D. / Moore, R. et al. | 2015
- A213
-
Promoting market access through breakthrough therapy designation: can this accolade help convince payers and prescribers?Duval, A. / Cox, J. et al. | 2015
- A214
-
Reimbursement Approval of Oncology Drugs In Canada Supported By a Data Package Lacking Phase III Trial DataMacaulay, R. et al. | 2015
- A215
-
Baseline characteristics of patients provided Cancer Care within a Novel Commercial Health Plan Cancer Care quality programWilley, V. / Quimbo, R. / Tunceli, O. / Mack, M. / Malin, J. et al. | 2015
- A216
-
Variations in primary treatment among Elderly Women with early stage Breast Cancer: associations with factors related to old age and Vulnerable Socio-DemographicsLeMasters, T. J. / Madhavan, S. S. / Sambamoorthi, U. / Kelly, K. / Hazard, H. / Long, D. et al. | 2015
- A217
-
The impact of Genomic testing on Chemotherapy use and medical spending in a commercially-insured population of Breast Cancer PatientsEpstein, A. J. / Wong, Y. / Mitra, N. / Vachani, A. / Hin, S. / Yang, L. / Smith-McLallen, A. / Armstrong, K. / Groeneveld, P. W. et al. | 2015
- A218
-
Comparison of expected Health impacts for Major Cancers:Integration of incidence rate and loss of quality-adjusted Life ExpectancyHung, M. / Lai, W. / Chen, H. H. / Su, W. / Wang, J. et al. | 2015
- A219
-
Barbec(EU)d Oncology market access – how BBQ pulled pork is similar to European P&R NegotiationsSwilling, N. / Altier, J. et al. | 2015
- A220
-
Oncology Drugs receiving breakthrough Therapy designation: clinical trial characteristics, Drug pricing, and Approval processPark, Y. / Vegesna, A. / Ray, D. / Tsang, Y. et al. | 2015
- A221
-
An evaluation of clinical remission and safety among Biologics for moderate-to-severe crohns disease: a Bayesian Network meta-analysisBounthavong, M. / Bae, Y. H. / Vanness, D. J. / Kazerooni, R. / Devine, B. et al. | 2015
- A222
-
Meta-analysis of Ultrasonic scalpel versus Electrocautery in Laparoscopic Cholecystectomy in ChinaYin, C. / Metz, L. et al. | 2015
- A223
-
Risk of Liver Transplant in treated vs. Untreated Hepatitis CEms, D. / Racsa, P. / Anderson, C. / Gregory, F. / Worley, K. et al. | 2015
- A224
-
A Cost-utility analysis of Biologics for moderate-to-severe Crohn’s disease: evidence synthesis using a Bayesian Network meta-analysisBounthavong, M. / Bae, Y. H. / Devine, B. / Veenstra, D. L. et al. | 2015
- A225
-
Cost effectiveness of Daclatasvir/Asunaprevir versus Peginterferon/Ribavirin and protease inhibitors for the treatment of Hepatitis C Genotype 1B in ChileVargas, C. / Espinoza, M. A. / Giglio, A. / Soza, A. et al. | 2015
- A226
-
Self-reported Health status of patients with Chronic Hepatitis B in ChinaLuo, N. / Zhang, M. / Zhang, S. / Shang, J. / Han, T. / Guo, Y. / Wang, X. / Liu, J. / Bo, Q. et al. | 2015
- A227
-
A Descriptive analysis of a Real-World Population with Chronic Hepatitis C (CHC) treated with Simeprevir (SMV)- and/or Sofosbuvir (SOF)-based regimens: findings from a us payer databaseForlenza, J. / Fortier, J. / Laliberté, F. / Lefebvre, P. / Tandon, N. et al. | 2015
- A228
-
Serious Adverse Events In Canadian Children Receiving Palivizumab for the Prevention of Respiratory Syncytial Virus InfectionChan, P. / Chen, J. / Paes, B. / Mitchell, I. / Li, A. / Lanctôt, K. et al. | 2015
- A229
-
Assessing Outcomes With Ceftaroline Treatment Compared with Standard of Care among Hospitalized Patients With Complicated Skin And Skin-Structure Infections (Csssi)Karve, S. / Hackett, J. / Levinson, J. et al. | 2015
- A230
-
Relative Efficacy of Simeprevir (Smv) Versus Telaprevir (Tpv) In The Treatment of NaÏVe Genotype 1 Chronic Hepatitis C Patients, Based on Indirect Comparison Using Patient-Level Clinical Trial DataDiels, J. / Thilakarathne, P. / Van Sanden, S. / Sbarigia, U. / Mehnert, A. et al. | 2015
- A231
-
Pharmacoepidemiology of Clostridial collagenase ointment for the treatment of Pressure Ulcers In outpatient Care SettingsGilligan, A. M. / Waycaster, C. R. et al. | 2015
- A232
-
Comparing First- and Second-Season Palivizumab Prophylaxis In Patients with Hemodynamically Significant Congenital Heart Disease in the Caress Database (2005-2014)Li, A. / Paes, B. / Mitchell, I. / Lanctôt, K. et al. | 2015
- A233
-
Cost-Utility analysis of three types of Influenza Vaccines (Trivalent, Trivalent High dose and quadrivalent) in adults aged 65 and Older Under Universal Influenza Immunization Program (UIIP) In Ontario, CanadaCheng, X. / Roïz, J. et al. | 2015
- A234
-
Recent trends in Urgent Antibacterial Threat-Related Hospitalization In the USReese, E. S. / Kurosky, S. K. / Candrilli, S. et al. | 2015
- A235
-
Costs and Challenges Associated with Diagnosis and Treatment of Infections In Hospitalized Patients: A Retrospective us Electronic Health Database StudyDurtschi, A. J. / Khangulov, V. S. / Peyerl, F. W. / Sammy, Y. et al. | 2015
- A236
-
A Cost-Effectiveness analysis of Pre-Exposure Prophylaxis for Hiv: a Us Payer PerspectiveVaidya, N. / Campbell, J. D. et al. | 2015
- A237
-
Economic Impact of Simulation-Based Training (SBT) for Central Venous Catheter (CVC) InsertionAsche, C. V. / Barker, L. / Ren, J. / Kim, M. / Kirkness, C. S. / McGarvey, J. / Short, J. / Vozenilek, J. et al. | 2015
- A238
-
The Cost effectiveness of a Novel High Priced Combination Therapy for Hepatitis C In Treatment NaÏVe Genotype 1 Infected PatientsMcGinnis, J. J. / Hay, J. W. et al. | 2015
- A239
-
Systematic Review of Economic Evaluation Studies of Vaccines In ChinaWen, Y. / Pan, X. / Griffiths, U. K. / Pennington, M. / Yu, H. J. / Jit, M. et al. | 2015
- A240
-
Cost/Utility analysis of Pneumococcal Vaccinees Pcv13 Versus Ppsv23 In Adults over 18 Years old in chileBiagini Leandro, L. / Rojas Ruben, R. / Fuentealba Francisca, F. / Pezzani Marcela, M. et al. | 2015
- A241
-
Knowledge Gaps About Pneumonia in older Adults: Baseline Results from the Pharmacists’ Pneumonia Prevention ProjectSchafer, J. J. / Steele, D. / Marthol, M. M. / Harris, L. F. / Pizzi, L. T. et al. | 2015
- A242
-
Assessing the Impact of Pegylated-Interferon/Ribavirin Therapy Duration Versus Viral Response on Health-Related Quality of Life (Qol) Outcomes In Chronic Hepatitis C Virus (Hcv) Patients, Using Multivariate Mixed-Effects ModelingThilakarathne, P. / Van Sanden, S. / Diels, J. / Mehnert, A. et al. | 2015
- A243
-
Encouraging orphan designation for new ebola treatments – could this do more harm than good?Macaulay, R. et al. | 2015
- A244
-
Resource Utilization and costs associated with multi-drug Resistant acinetobacter Baumannii: a Systematic Review of The LiteratureSchmier, J. / Hulme-Lowe, C. / Klenk, J. / Sulham, K. et al. | 2015
- A245
-
Pneumococcal vaccination Coverage In adults with high-risk Conditions: Missed Opportunities ContinueYang, H. K. / Zhang, D. / Shao, C. / Grabenstein, J. et al. | 2015
- A246
-
Real-World Practice Patterns For The Treatment Of Complicated Skin And Skin Structure Infections In Europe: A Retrospective Database AnalysisSulham, K. / Fan, W. / Plent, S. et al. | 2015
- A247
-
Sentinel site active Surveillance of the safety of first-line Antiretroviral medicines in NamibiaMann, M. / Mengistu, A. / Gaeseb, J. / Sagwa, E. / Mazibuko, G. / Garrison, L. P. / Stergachis, A. et al. | 2015
- A248
-
Performance of two World Health Organization Dengue classifications in a Pediatric Cohort from ColombiaPinzón-Redondo, H. / Paternina-Caicedo, A. / Alvis-Guzman, N. / Diaz-Quijano, F. / Zarate-Vergara, A. / Barrios-Redondo, K. / De la Hoz-Restrepo, F. et al. | 2015
- A249
-
Predictors of Cigarette Smoking in Three Asian Countries: China India and TaiwanAlmogbel, Y. / Abughosh, S. / Essien, E. J. / Sansgiry, S. S. et al. | 2015
- A250
-
Burden of disease of Hepatitis C in ColombiaAlvis-Guzman, N. / Romero, M. / De la Hoz-Restrepo, F. et al. | 2015
- A251
-
Economic burden of adverse events associated with first line Metastatic Renal Cell Carcinoma (MRCC) treatment in public and Private Brazilian PerspectiveFerreira, C. N. / Santana, C. F. / Rufino, C. S. et al. | 2015
- A252
-
Common reasons for and associated costs of Pediatric inpatient admissions in the United StatesMeyers, J. / Candrilli, S. et al. | 2015
- A253
-
Cost of Colorectal Cancer in VietnamNguyen, T. / Phan, T. / Nguyen, T. T. et al. | 2015
- A254
-
Medical care costs of Chikungunya Virus infection in a Pediatric Population in ColombiaCastañeda-Orjuela, C. / Díaz-Jiménez, D. / Rodríguez-Castillo, L. / Paternina-Caicedo, A. / Pinzón-Redondo, H. / Alvis-Guzman, N. / De la Hoz-Restrepo, F. et al. | 2015
- A255
-
Estimating the cost of Pneumonia cases admitted at the internal medicine wards of a tertiary Government Hospital in the PhilippinesRivera, A. S. et al. | 2015
- A257
-
Cost-effectiveness of a Behavioral Psychosocial treatment integrated across Home and School for Pediatric ADHD-Inattentive typeTran, J. L. / Sheng, R. / Esonwune-Chukwudi, P. / Beaulieu, A. / McBurnett, K. / Pfiffner, L. J. / Wilson, L. et al. | 2015
- A258
-
Expected costs and Health outcomes for a Cohort of Albertans diagnosed with Hepatitis CThanh, N. X. / Jacobs, P. / Waye, A. / Tyrrell, D. L. / Misurski, D. et al. | 2015
- A259
-
Impact of Email refill reminders on medication adherence among patients with Chronic Diseases in a retail Community PharmacyTaitel, M. S. / Mu, Y. / Lou, Y. / Cannon, A. et al. | 2015
- A260
-
Impact of structured patient Education on quality of life of South Indian DiabeticsTalla, V. / Yellu, N. R. / Pippalla, S. R. / Rao, V. / Pattnaik, S. / Subudhi, S. / Budike, R. / Pandalaneni, A. et al. | 2015
- A261
-
HEALTH RELATED QUALITY OF LIFE AND HEALTH CARE RESOURCE USE BURDEN IN MIGRAINE WITH AND WITHOUT NAUSEAFlores, N. M. / Lee, L. K. / Gajria, K. / Pomerantz, D. / Gandhi, S. K. et al. | 2015
- A262
-
Geographic patterns of self-reported Lifetime Depression DiagnosisTobo, B. B. / Adjei Boakye, E. / Buchanan, P. et al. | 2015
- A263
-
Relative age in class and ADHD in School Children – Diagnosis and Medication patterns – Intra-Annual and Inter-Annual DisparityHoshen, M. B. / Benis, A. / Keyes, K. M. / Zoega, H. et al. | 2015
- A264
-
Healthcare resource use among Patients with congestive Heart failure in a Large Health OrganizationBash, L. D. / Weitzman, D. / Sharon, O. / Aviram-Paz, M. / Chodick, G. / Shalev, V. et al. | 2015
- A265
-
Prevalence and determinants of Low-Cost Generic Drug program use in the privately-insured Adult PopulationPauly, N. / Brown, J. et al. | 2015
- A266
-
Human Papillomavirus (HPV) Vaccination during well-Child visits in privately insured Males 9-21 years of age in the United States in 2012Zhang, D. / Huang, M. / Kulkarni, A. S. / Niccolai, L. M. et al. | 2015
- A267
-
The impact of Patient Centered Medical Home in a Managed Medicaid PopulationChu, L. et al. | 2015
- A268
-
Is visual impairement associated with increased Hospitalization? a retrospective Cohort study of community-dwelling medicare beneficiaresTsang, Y. / Tom, S. / Onukwugha, E. et al. | 2015
- A269
-
Cost study on Provincial General HospitalsGantugs, Y. / Otgonbayar, D. / Tsolmongerel, T. et al. | 2015
- A270
-
Colorectal Cancer (CRC) costs in the us: findings from the Medical Expenditure Panel Survey 2008-2012Haider, M. R. / Qureshi, Z. / Horner, R. / Xirasagar, S. / Khan, M. M. et al. | 2015
- A271
-
Characteristics of Drug Therapy problems and response rate in Telephonic comprehensive medication reviews provided to 2014 medicare part D BeneficiariesWong, J. et al. | 2015
- A272
-
Impact of case management Nurses on cancer Patients: a Systematic ReviewBregman, C. / Doutriaux, A. / Cognet, M. / Gauthier, A. / Pourcel, G. / Ferrari, C. / Viguier, J. et al. | 2015
- A273
-
Healthcare Burden of cervical cancer in a national Medicaid managed care populationJoshi, N. / Khanna, R. / Pace, P. et al. | 2015
- A274
-
Prevalence of Mental Health Disorders and access to care among children Enrolled in the mississippi medicaidNunna, S. / Shah, R. / Banahan, I. B. / Hardwick, S. P. / Clark, J. P. et al. | 2015
- A275
-
Quality and Implementation Barriers of Prevention of Mother to child transmission of hiv Program in Ethiopia: a cross sectional studyLegesse, B. et al. | 2015
- A276
-
Outpatient Follow-Up Visits After Hospital Discharge for Mental Illness and Implications for re-admissionsLin, I. / Muser, E. / Munsell, M. / Menzin, J. et al. | 2015
- A277
-
Comparative Study of The Influence of Biapenem and Meropenem on Valproic acid blood concentrationTang, L. et al. | 2015
- A278
-
Total Migraine freedom for breath powered intranasal delivery of 22 mg Sumatriptan Powder (Avp-825) Versus 100 mg oral sumatriptan from the compass study of acute treatment of MigraineHalker, R. / Tepper, S. / Siegert, S. / Wallick, C. et al. | 2015
- A279
-
“Number Needed to treat” analysis to Assess the comparative outcomes from Teriflunomide and dimethyl fumarate studies in relapsing multiple sclerosisLeist, T. / Montalban, X. / Miller, A. / Dive-Pouletty, C. / Freedman, M. et al. | 2015
- A280
-
Budget Impact of adding peginterferon beta-1a to the formulary for the treatment of relapsing forms of multiple SclerosisMauskopf, J. / Graham, J. / Fay-Azhar, M. / Kinter, E. et al. | 2015
- A281
-
A Comparison of Healthcare Resource utilization and associated costs in adults with generalized convulsive seizures (GCS)Li, X. / Barghout, V. / Wang, Z. et al. | 2015
- A282
-
A Retrospective Analysis of the Economic Burden Among Patients Diagnosed with Chronic Migraine using the Veterans Health Administration Medical dataMao, X. / Shrestha, S. / Baser, O. / Wang, L. et al. | 2015
- A283
-
Cost Effectiveness of Early Treatment of Parkinson’s Disease in MexicoMarquez, M. / Diaz, J. / Pizarro, M. / Ibarra, A. / Cervantes, A. / Rodríguez, M. / Soto, H. et al. | 2015
- A284
-
Skeletal Muscle activity and Resource tool for sporadic Inclusion body Myositis (Smart-Sibm): Characterization of Resource Utilization and Financial Burden Experienced By Sibm PatientsBarghout, V. / DeMuro, C. / Price, M. / Lewis, S. / Tseng, B. et al. | 2015
- A285
-
What are people willing to pay for whole genome sequencing information?Marshall, D. A. / Gonzalez, J. M. / Johnson, F. R. / Pugh, A. / MacDonald, K. V. / Douglas, M. P. / Phillips, K. A. et al. | 2015
- A286
-
Sex Differences In over-the-counter sleep aid use in older adultsGross, H. J. / O’Neill, G. / Toscani, M. / Chapnick, J. et al. | 2015
- A287
-
Quality of Life in neuromyelitis optica: a Systematic reviewLikhar, N. / Dang, A. et al. | 2015
- A288
-
Willingness-to-Pay for Newborn Genetic Testing for Spinal Muscular AtrophyLin, P. / Shi, J. / Yeh, W. / Neumann, P. J. et al. | 2015
- A289
-
Healthcare resource utilization associated with rescue Medication use in adult Patients With Seizure Clusters: a retrospective chart ReviewVazquez, B. / Sidovar, M. / Squillacote, D. / Wu, E. / Macaulay, D. / Sorg, R. / Guo, A. et al. | 2015
- A290
-
Oral disease modifying therapy for multiple sclerosis; is this the new normal?Johnson, B. H. et al. | 2015
- A291
-
A Review of intraoperative interventions to prevent staple line leaks and Bleeds during Bariatric Surgical ProceduresGhosh, S. K. / Roy, S. / Chekan, E. / Fegelman, E. et al. | 2015
- A292
-
Comparison of disease status and outcomes of Patients with Ankylosing Spondylitis (AS) receiving adalimumab or Etanercept Monotherapy in the United States (US)Narayanan, S. / Lu, Y. / Hutchings, R. / Graham, C. M. / Baynton, E. et al. | 2015
- A293
-
Second prospective, Pharmacoepidemiologic database analysis of Phentermine and Topiramate extended-release usage from a representative us sample of Older PatientsPeterson, C. A. / Steelman, X. / Varghese, S. T. et al. | 2015
- A294
-
Economic implications of increasing usage of Calcium-Free balanced crystalloid solutions (BAL) versus 0.9% saline for intravenous (IV) fluid Therapy in patients with Systemic Inflammatory Response Syndrome (SIRS) in us HospitalsMakhija, D. / Munson, S. / Khangulov, V. S. / Peyerl, F. W. / Paluszkiewicz, S. M. / Laplante, S. / Liu, F. X. et al. | 2015
- A295
-
Comparing the Economic burden of various Diseases from a Payer’s perspective in ChinaWang, B. C. / Chen, Y. / Furnback, W. / Yang, R. / Xie, L. et al. | 2015
- A296
-
Direct Healthcare Costs of Opioid Abuse in Patients prescribed immediate release Hydrocodone in the United StatesMichna, E. / Chitnis, A. / Paramore, C. / Holly, P. / Bell, J. A. / BenJoseph, R. et al. | 2015
- A297
-
Demonstrating the cost effectiveness of Movantik for the treatment of opioid induced constipation in Patients with inadequate response to Laxatives; a UK perspectiveLawson, R. / Vioix, H. / Mudunkotuwe, S. / King, F. / Goh, J. / Marsh, K. et al. | 2015
- A298
-
Cost-utility analysis of Pain Medications used to treat Adult Patients with Chronic Back Pain in the United StatesShah, D. / Anupindi, V. R. / Vaidya, V. et al. | 2015
- A299
-
Estimating Utility values for Polycythemia vera using patient-reported outcomes from the response trial and existing Mapping AlgorithmsThompson, M. / Pepper, A. N. / Côté, I. / Oliver, N. et al. | 2015
- A300
-
Ibrutinib for the treatment of Mantle Cell Lymphoma (MCL): evaluating the correlation between patient-reported outcomes and durability of response in a Phase 2 studyRule, S. / Goy, A. / Martin, P. / Ramchandren, R. / Alexeeva, J. / Popat, R. / Avivi, I. / Advani, R. / Le Gouill, S. / Horowitz, N. et al. | 2015
- A301
-
Pain Functional Impairment and Quality of Life (P-FIQ): an assessment of reliability of five patient reported outcome (PRO) instruments in Adult People with Hemophilia (PWH)Kempton, C. L. / Wang, M. / Recht, M. / Neff, A. / Shapiro, A. D. / Buckner, T. / Kulkarni, R. / Nugent, D. / Batt, K. / Wisniewski, T. et al. | 2015
- A302
-
Determining patterns of Opioid misuse and misprescribing in South CarolinaQureshi, Z. / Ball, S. / Horner, R. / Kreiner, P. / Lopez-Defede, A. / Probst, J. / Bennett, C. et al. | 2015
- A303
-
Dosing pattern analysis for Biologics in the treatment of Psoriasis in Canada: indication-specific information retrieved from Administrative Claims DatabaseGregory, V. / Liu, N. / Robertson, C. / Gerega, S. / Barbeau, M. / Budry, L. et al. | 2015
- A304
-
Canadian retrospective claims data analysis of Biologics switching and retention patterns in Psoriasis PatientsMillson, B. / Poulin-Costello, M. / Garces, K. et al. | 2015
- A305
-
Why ask if you know? Acmg’s potential errors in making Newborn screening (NBS) recommendations from using surveyed opinions for incidence scoring when actual data are availableAlgarni, M. / Almutairi, H. / Rittenhouse, B. et al. | 2015
- A306
-
Assessing the impact of varying threshold criteria for Opioid OverutilizationDurkin, M. / Moll, K. / Pasquale, M. K. / Amos, T. / Null, K. D. et al. | 2015
- A308
-
Research Presentations Financial Disclosure Statements| 2015
- A319
-
ISPOR 20th Annual International Meeting Research Abstracts Author Index| 2015
- i
-
Table of Contents| 2015
- I
-
Instructions for Authors| 2015
-
Reducing And Quantifying Over-Fitting In Regression ModelsRigg, J. / Hankins, M. et al. | 2015
-
A review of the literature regarding biosimilars: what is the evidence for equivalence?Raisch, D. W. / Chen, C. / Tuenter, H. / Bennett, C. / IJzerman, M. J. et al. | 2015
-
Extrapolating All-Cause Mortality Estimates In Economic Evaluations: A Simulation AnalysisPechlivanoglou, P. / Abrahamyan, L. / Paulden, M. / Pham, B. / Krahn, M. D. et al. | 2015
-
The Impact Of Chronic Conditions On The Economic Burden Of Cancer Survivorship In The United StatesGuy, G. / Ekwueme, D. / Li, R. / Rim, S. H. / Yabroff, K. R. et al. | 2015
-
US Based Drug Cost Parameter Estimates Using National Average Drug Acquisition CostLevy, J. F. / Rosenberg, M. A. / Vanness, D. J. et al. | 2015
-
Can’t we just use this portuguese translation in brazil? Analysing why there is more to country-specific pros than ticking/checking boxesSimpson, H. / Bellhouse, G. / Neal, R. / Two, R. et al. | 2015
-
Exploring Heterogeneity In Attribute Processing Strategies: Use Of Hybrid Random Utility Maximization-Random Regret Minimization (Rum-Rrm) Models In A Discrete Choice Experiment (Dce)Chaugule, S. / Hay, J. W. / Young, G. et al. | 2015
-
Improving Parameter Estimation For A Decision-Analytic Markov Model To Evaluate The Use Of Novel Biomarker Led Strategies For Prevetion Of Cardiovascular DiseaseLamrock, F. / Cairns, K. / Kee, F. / Conrads-Frank, A. / Schnell-Inderst, P. / Salomaa, V. / Blankenberg, S. / Zeller, T. / Saarela, O. / Kuulasmaa, K. et al. | 2015
-
Cost-Benefit Analysis Of Whole Body Bone Scintigraphy In The Pre-Transplant Assessment Of Adult Patients, Bearers Of Hepatocellular Carcinoma, In A Liver Transplant Waiting List, From Dead Donors, In A Reference Hospital In The South Of BrazilBalbinotto, G. / BrandÃo, A. / Rodriguez, S. et al. | 2015
-
Models Used In Economic Analyses Of Ticagrelor And Prasugrel For Acute Coronary Syndromes: A Structured ReviewLaw, E. H. / Sharma, D. / Pickard, S. et al. | 2015
-
Why Peer-Review Journals Reject Real-World And Health-Economic PapersHartog, T. E. / Peters, K. / Diamond, M. / Nuottamo, N. et al. | 2015
-
National Burden Of Hospitalizations For Necrotizing Enterocolitis: Results From The 2009 Kid’s Inpatinet DatabaseJiao, X. / Han, X. et al. | 2015
-
An economic model of the impact of digital medicines with a Mobile application in patients with Comorbid Hypertension, Diabetes, and HypercholesterolemiaKim, Y. A. / Raja, P. / DiCarlo, L. / Virdi, N. / Park, H. et al. | 2015
-
Budget impact of Percutaneous Endovascular Abdominal Aorta Aneurysm (AAA) repair compared to standard Endovascular repair in Canadian HospitalsOndrejicka, D. A. / Hazel, M. et al. | 2015
-
Cost effectiveness of left atrial appendage closure versus Warfarin for stroke risk reduction in non-valvular Atrial Fibrillation in CMS patientsReddy, V. / Akehurst, R. / Amorosi, S. L. / Armstrong, S. / Beard, S. / Knight, C. / Taggart, C. / Holmes, D. et al. | 2015
-
Economic evaluation of paclitaxel-eluting balloon catheter for Percutaneous Transluminal Angioplasty (PTA) in Mexican Population with Peripheral Arterial Obstructive DiseaseCeballos, R. / Orozco, J. J. / Soto, H. / Carmona, M. / Escobar Juárez, Y. et al. | 2015
-
Utilization of Colorectal Screening by medicare beneficiaries in years 2009 and 2011: a cross-sectional studySieluk, J. / Tom, S. / Stuart, B. et al. | 2015
-
Can serologic markers of Fibrosis predict future shocks in ICD recipients with dilated Cardiomyopathy?Kanoupakis, E. / Fanourgiakis, J. A. / Kallergis, E. / Mavrakis, H. / Saloustros, I. / Koutalas, E. / Vernardos, M. / Chlouverakis, G. / Vardas, P. et al. | 2015
-
Efficacy and safety of an extended-release metformin Formulation In Type-2 Diabetes Mellitus Treatment: A Systematic ReviewFujii, R. K. / Restrepo, M. / Fernandes, R. A. / Haas, L. / Pepe, C. / Turatti, L. A. / Junqueira, M. et al. | 2015
-
Glycated Hemoglobin (Hba1c) Control In Patients with Type 2 Diabetes Mellitus (T2dm) Treated with Canagliflozin In a real-world settingLefebvre, P. / Pilon, D. / Robitaille, M. / Lafeuille, M. / Chow, W. / Pfeifer, M. / Duh, M. S. et al. | 2015
-
Economic impact of dapagliflozin vs. Other antidiabetic drugs for the treatment of patients with type 2 diabetesLin, J. / Dhankhar, P. / Bell, K. / Chhatwal, J. / Lingohr-Smith, M. et al. | 2015
-
Using a treatment transition model to Evaluate the Effects of Neglecting Hba1c Drift In oral anti-diabetic Drugs for Type 2 DiabetesSmolen, H. J. / Yu, X. et al. | 2015
-
Adherence to Liraglutide once daily or exenatide once weekly Over A 12-Month period among Commercially Insured Patients With Type 2 diabetes Mellitus: A retrospective observational studyJohnston, S. / Nguyen, H. / Cappell, K. A. / Nelson, J. / Chu, B. / Kalsekar, I. et al. | 2015
-
Investigating the Short-Term Impact of Poor Glycemic Control on the daily lives of People with type 2 DiabetesJendle, J. / Ridderstråle, M. / Jensen, H. H. / Bøgelund, M. / Jensen, M. M. / Ericsson, A. / Evans, M. et al. | 2015
-
Attitudes towards Collaboration among Nurses and Physicians practicing in Newly Established Medical homesAlcusky, M. J. / Ferrari, L. / Rossi, G. / Liu, M. / Maio, V. et al. | 2015
-
Effect of the U.S.-Peru free trade agreement on Peruvian new Drug policies and the registration of Pharmaceutical ProductsAraujo, L. E. / Montagne, M. et al. | 2015
-
A Framework for strengthening Pharmaceutical Manufacturing in Sub-Saharan AfricaMann, M. / Adamson, B. J. / Rennie, T. / Stergachis, A. et al. | 2015
-
Effect of Patient’s cost sharing on Expenditures: an Instrumental Variables ApproachKawatkar, A. A. et al. | 2015
-
Medication use survey of inpatients with basic Medical Insurance from 2010 to 2012Xiong, X. / Li, J. / Zhang, J. / Ma, Y. / Gao, S. Q. / Yang, L. et al. | 2015
-
Communicating risk of Medication side effects: how rare is ‘rare’ and how likely is ‘likely’?Sawant, R. V. / Sansgiry, S. S. et al. | 2015
-
Is there an Association between potentially inappropriate prescribing in the elderly and Hospitalization and Mortality? a Longitudinal, large Cohort studyVegesna, A. / Alcusky, M. J. / Keith, S. W. / Hegarty, S. E. / Del Canale, S. / Lombardi, M. / Maio, V. et al. | 2015
-
Emergency disease Spectrum in China: based on Hospital database from BeijingLiu, Y. / Wu, J. / Zhang, J. et al. | 2015
-
Key Milestones Of Public-Private Partnerships For Drugs In BrazilSaggia, M. et al. | 2015
-
Access to medicine, reimbursement and pricing in germany: what are the implications of amnog?Mueller, E. / Schmidt, E. / Schrank, L. / Neeser, K. et al. | 2015
-
Evaluating Global Early Market Access Opportunities For Innovative Therapies: Focus On Japan, Uk And UsCarr, D. R. / Anastasaki, E. / Bradshaw, S. E. et al. | 2015
-
Health Data Entanglement And Artificial Intelligence-Based Analyses To Improve The Effectiveness Of Services And Tackle The Healthcare Spending GrowthCapone, A. / Mennini, F. S. / Cicchetti, A. / Marcellusi, A. / Baio, G. / Torlone, R. / Favato, G. et al. | 2015
-
Population Based Valuation Of Private Annuity And Life Insurances Under Taiwan’s National Health Insurance SystemHsu, W. W. / Wu, Y. / Yu, P. / Hsieh, H. / Ho, J. et al. | 2015
-
Assessment Of Medication Adherence Among Patients With Non-Communicable Chronic Diseases In Quetta Baluchistan, Pakistanul Haq, N. / Shaheen, H. / Iqbal, Q. / Naseem, A. / Razaq, G. / Younis, M. / Iqbal, J. et al. | 2015
-
Prevalence And Predictors Of Health Risk Behaviors In Undergraduate Health Sciences Students Of Khyber Medical UniversityShah, S. / Imtiaz, A. / Mahsood, N. / Ahmad, N. / Basit, A. / Ayub, A. et al. | 2015
-
For Two Companies The Fda Pro Guidance Leads To Similar But Different Measures: A Case Study In PsoriasisMordin, M. / Brown, T. / McLeod, L. / DeMuro, C. / Gnanasakthy, A. et al. | 2015
-
The impact of anxiety on Healthcare Utilization and costs among respondents from the Co-Morbidities and Symptoms of depression (CODE) studyStephenson, J. J. / Grabner, M. / Faries, D. / Palli, S. R. / Robinson, R. et al. | 2015
-
Racial/Ethnic differences in the use of Complementary and Alternative Medicine in Adults with moderate Mental Distress: results from 2012 National Health Interview SurveyRhee, T. G. / Johnson, P. J. / Evans, R. L. / McAlpine, D. D. et al. | 2015
-
Prevalence and Correlates of non-medical use of prescription stimulants among University StudentsShanbhag, P. P. / Nayak, R. et al. | 2015
-
The concentration of Antipsychotic prescribing: Evidence from MedicaidTang, Y. / Chang, C. H. / Huskamp, H. / Gellad, W. F. / Donohue, J. M. et al. | 2015
-
Evidence Requirements For Future Antiarrhythmic Treatments For Atrial Fibrillation (Af)Black, J. / Proach, J. et al. | 2015
-
Generic Drug Discount Programs And Their Potential Impact On The Completeness Of Pharmacy Claims DataThompson, J. A. / Kelton, C. M. / Heaton, P. C. et al. | 2015
-
Hospitalization Costs For Patients With Heart Failure Using Claims Database €“ A Comparison Between Commercial And Medicare Advantage PopulationKielhorn, A. / Maya, J. / Song, R. / Henk, H. J. / Patel, H. et al. | 2015
-
The Impact Of Stroke Centers On The Length Of Stay Among Ischechemic Stroke Patients In AlbertaOhinmaa, A. / Zheng, Y. / Jeerakathil, T. / Nguyen, T. / Klarenbach, S. / Hakkinen, U. / Kaul, P. / Friesen, D. / Ruseski, J. / Ariste, R. et al. | 2015
-
Comparative Effectiveness Of Angiotensin Converting Enzyme Inhibitors And Angiotensin Ii Receptor Blockers In Heart FailureSharma, M. / Johnson, M. L. / Chen, H. / Aparasu, R. et al. | 2015
-
Trends in antihypertensive medication use in us office-based practices: are elderly patients treated diffrerently?Gu, A. / Yue, Y. / Argulian, E. et al. | 2015
-
Economic Implications Of Increased Utilization Of 5% Albumin For Fluid Resuscitation Post On-Pump Cardiac Procedures In Us HospitalsRunken, M. C. / Khangulov, V. S. / Munson, S. H. / Peyerl, F. W. / Bunke, M. et al. | 2015
-
Determinants Of Utility Based On The Eq-5d In Chronic Heart Failure Patients And Their Change Over Time: Results From The Swedish Heart Failure RegistryBerg, J. / Lindgren, P. / Mejhert, M. / Edner, M. / Dahlström, U. / Kahan, T. et al. | 2015
-
The 5 principal causes of death in mexico in the last 5 years, is the public health system covering these needs?Lemus, F. / Rivas, R. et al. | 2015
-
The Use Of Statins Among Prior-Users After HemodialysisShih, Y. / Liu, Y. / Huang, W. / Wen, Y. / Tsai, Y. et al. | 2015
-
Long-Term Failure Rates Associated With Knee Microfracture SurgeryLayton, A. / Arnold, R. J. / Graham, J. / Frasco, M. A. / Cote, E. / Lynch, N. M. et al. | 2015
-
Patient-Reported Outcomes (Pros) In Bladder CancerBarsdorf, A. / Pease, S. et al. | 2015
-
Patient- and Physician-Reported Motivations for Medication Non-Adherence or Switching In Rheumatoid ArthritisSmalarz, A. / Prado, M. et al. | 2015
-
Evaluation of disease activity in patients diagnosed with rheumatoid arthritis: how often and to what detail are assessments documented?Smalarz, A. / Prado, M. et al. | 2015
-
Infiltration of Liposomal Bupivacaine (LB) Decreases Length of Hospitalization Following Total Knee Arthroplasty (TKA)Kirkness, C. S. / Asche, C. V. / Ren, J. / Gordon, K. / Maurer, P. / Maurer, B. / Maurer, B. T. et al. | 2015
-
Content Validity Evaluation of A New Diary Developed to Evaluate Symptoms Important to Patients With Moderate to Severe Rheumatoid ArthritisDeLozier, A. M. / Gaich, C. L. / Vernon, M. K. / von Maltzahn, R. et al. | 2015
-
Association Between Sedative-Hypnotics Use and Falls In Community-Dwelling Older AdultsPark, Y. / Tom, S. / Stuart, B. et al. | 2015
-
Cost-Effectiveness of Refractory Asthma Treatment Strategies: A Decision Tree AnalysisBogart, M. / Roberts, A. / Wheeler, S. et al. | 2015
-
Cost-Consequence of Eosinophilic Asthma Among Patients Treated According to Ers/Ats GuidelinesCasciano, J. / Krishnan, J. / Buatti-Small, M. / Li, C. / Dotiwala, Z. et al. | 2015
-
Assure-Csu Canadian Results: Assessing Health Utility In Chronic Spontaneous/Idiopathic Urticaria Using The Eq-5dSussman, G. / Waserman, S. / Keith, P. / Chiva-Razavi, S. / Chambenoit, O. / Hollis, K. / McBride, D. / Westlund, R. / Tian, H. / Balp, M. et al. | 2015
-
Impact of Pharmacists-Led Interventions to Assess Knowledge, Attitude And Perception Among Tuberculosis Patients In Pakistan: An Insight From A Randomized Controlled Non Clinical TrialIqbal, M. S. / Iqbal, M. Z. / Iqbal, M. W. / Bahari, M. B. / Nasir, S. et al. | 2015
-
A review of health-related quality of life (hrql) claims in labels of asthma products – can we consider the asthma quality of life questionnaire (aqlq) as a potentially acceptable measure for qualification?Acquadro, C. / Conway, K. / Juniper, E. F. / Perret, C. et al. | 2015
-
Return on Investment of Smoking Cessation Benefit Comparison In Guangdong, ChinaLiu, D. / Zhu, S. / Dong, P. et al. | 2015
-
Comparing total and disease specific Healthcare costs for Glaucoma Patients before and after their index Diagnosis: a retrospective claims database analysisYep, T. / Patel, V. / Slejko, J. F. / Devine, B. et al. | 2015
-
Cost of Illness, Diagnosis and treatment patterns for Diabetic Macular Edema across 13 CountriesMcLeod, E. / Lovato, E. / Wittrup-Jensen, K. U. / Muston, D. R. et al. | 2015
-
Benefits of patient-reported outcomes in Dermatology Drug DevelopmentCopleymerriman, C. / Zelt, S. / Clark, M. / Gnanasakthy, A. et al. | 2015
-
Availability and affordability of Antiglaucoma Drugs in Benin City, NigeriaUsifoh, S. et al. | 2015
-
Economic Burden Of Antibody Mediated Rejection Following Kidney Transplantation: Comparative Analysis Using The Premier Hospital DatabaseIrish, W. / Boscoe, A. / Ryan, M. P. / Iloeje, U. / Gunnarsson, C. / Marks, W. et al. | 2015
-
Measurement of Health State Utilities For Relapsed or Refractory Peripheral T-Cell Lymphoma By using time trade-off And Visual Analog Scale MethodKang, H. N. / Choi, I. / Song, H. / Park, S. / Suh, D. et al. | 2015
-
The Disconnect Between Funding Decisions of Cancer Drugs And Companion Diagnostic Tests in CanadaPoinas, A. / Wyatt, G. et al. | 2015
-
Opioid Prescription Trends in The Rural Us: Evidence From The National Ambulatory Medical Care Survey (Namcs) Data 2006-2010Qureshi, Z. / Haider, M. R. / Probst, J. / Horner, R. / Bennett, C. et al. | 2015
-
Is metformin exposure associated with improved survival in head and neck cancer patients? a large population-based cohort studyAlcusky, M. J. / Keith, S. / Karagiannis, T. S. / Rabinowitz, C. / Louis, D. / Maio, V. et al. | 2015
-
Choice of Sequential Biological Therapies In Metastatic Colorectal Cancer (Mcrc): a Cost Comparison Analysis For Wild-Type Kras Mcrc Patients In BrazilTsuchiya, C. T. / Kim, H. S. / La Scala, C. S. et al. | 2015
-
Systematic Review of Economic Evaluations in allogeneic Hematopoietic Stem Cell TransplantationLachaine, J. / Lachance, S. / Lambert-Obry, V. / Bibeau, J. et al. | 2015
-
Estimation of direct healthcare costs of gynecologic cancer in the u.s.: an analysis of 2007-2011 medical expenditure panel survey (meps) dataPark, C. / Lawson, K. A. et al. | 2015
-
Cost-Effectiveness of a Biopsy-Based 8-Protein Prognostic Assay to Optimize Treatment Decisions In Gleason 3+3 And 3+4 Prostate CancerRoth, J. A. / Ramsey, S. / Carlson, J. J. et al. | 2015
-
Long-Term outcomes of Hpv Vaccination In Prevention of Anal Cancer In older Hiv-Positive Men Who Have Sex With MenDeshmukh, A. A. / Chhatwal, J. / Chiao, E. Y. / Nyitray, A. G. / Das, P. / Cantor, S. B. et al. | 2015
-
Determinants for guideline appropriate care among Elderly Women with stage I-III Breast Cancer in a Seer-Medicare PopulationLeMasters, T. J. / Madhavan, S. S. / Sambamoorthi, U. / Kelly, K. / Hazard, H. / Long, D. et al. | 2015
-
BUDGET IMPACT ANALYSIS OF HEPATITIS C DRUGS IN MED-CALNaku, F. et al. | 2015
-
Development and Validation of a clostridium difficile quality of life QuestionnaireGarey, K. / Aitken, S. / Gschwind, L. / Goddu, S. / Xie, Y. / Duff, C. / Shah, D. N. et al. | 2015
-
A Large-Scale Cross-Sectional Study of Hiv Infection among Male Clients over 50 years old in low-cost commercial sex venues of Guangxi,ChinaWu, X. / Feng, X. / Kelly, C. / Shen, Z. / Chen, H. / Lu, H. / Luo, L. / Chen, L. / Ruan, Y. / Tang, Z. et al. | 2015
-
Determinants of Pertussis outbreaks and Lessons LearntMillier, A. / Briquet, B. / Khemiri, A. / Roïz, J. / Toumi, M. et al. | 2015
-
Survival Analysis of HIV and aids Treatment In KenyaOwiti, E. A. et al. | 2015
-
A Cost-effectiveness and Budget Impact Analysis of Fidaxomicin for Treating Clostridium Difficile Patients In GermanyWatt, M. / McCrea, C. / Johal, S. / Posnett, J. / Nazir, J. et al. | 2015
-
Economic Analysis of Empiric Versus Diagnostic-Driven Strategies for Immunocompromised Patients With Suspected Aspergillus Invasive Fungal Infections In ChinaQin, L. / Chen, Y. / Lesher, B. / Liu, Q. / Charbonneau, C. / Earnshaw, S. R. / McDade, C. / Mao, N. / Gao, X. et al. | 2015
-
Projecting Changes in total days of therapy (DOT) In Patients Hospitalized for Acute Bacterial Skin and Skin Structure Infection (Absssi)Berger, A. / Kauf, T. / Oster, G. et al. | 2015
-
Evaluation of Economic Impact of tuberculosis control In Malaysia Using Dynamic Transmission ModelFun, W. H. / Wu, D. B. / Cheong, Y. M. / Mohamad Noordin, N. / Lee, K. K. et al. | 2015
-
Predictors of Allopurinol adherence in patients with GoutJ.a., S. et al. | 2015
-
Frequent Emergency department use among non-elderly Adults: analysis of multi-state medicaid claims dataAgarwal, P. / Bias, T. / Frisbee, S. / Sambamoorthi, N. / Bose, S. / Madhavan, S. S. / Sambamoorthi, U. et al. | 2015
-
Preventing Cervix-Uterus Cancer in Argentina. Structrure, Organization and ResultsMaceira, D. et al. | 2015
-
A Novel Stillbirth Audit tool implementation in Ghana: assessment of deployment in 2014Davies-Teye, B. B. / Baison, H. M. / Oduro-Mensah, E. / Vanotoo, L. et al. | 2015
-
The market for Hepatitis C services in AlbertaThanh, N. X. / Misurski, D. / Waye, A. / Jacobs, P. / Tyrrell, D. L. et al. | 2015
-
Cost of primary and secondary Healthcare Utilization for patients with irritable bowel Syndrome calculated using routinely collected Electronic records to assess the impact of secondary care referralCanavan, C. / Card, T. / West, J. et al. | 2015
-
Peripheral arterial disease management program: screening-risk factor management program and financial return on investmentLuque, A. / Junqueira Junior, S. M. / Cabra, H. A. / Andrade, P. C. / Oliveira, F. M. et al. | 2015
-
Direct medical cost of complications in patients with Non Valvular Atrial Fibrillation NVAF at a Private Hospital in VenezuelaFernandez, Y. / Chiquinquira, K. / Garrido Lecca, S. et al. | 2015
-
Economic burden of Colorectal Cancer in Vietnam: from Healthcare payers’ perspectivePhan, T. / Hoang, B. / Nguyen, T. T. et al. | 2015
-
An accessible approach to estimate the direct medical costs of type 2 Diabetes mellitus for the Brazilian National Health SystemAquino, C. M. / Lima, R. C. / Marinho, M. G. / Sousa, I. M. / Cesse, E. / Bezerra, A. F. et al. | 2015
-
Estimating Healthcare resource use associated with the treatment of Metastatic Melanoma in Eight CountriesMcKendrick, J. / Gijsen, M. / Quinn, C. / Zhao, Z. / Barber, B. L. et al. | 2015
-
A Vision ‘Bolt-On’ item increased the sensitivity of EQ-5D in a cross-sectional Health SurveyWang, X. / Ang, M. / Finkelstein, E. A. / Aung, T. / Wong, T. Y. / Lamoureux, E. / Luo, N. et al. | 2015
-
Specialty Pharmacy Medication compliance and persistence program for patients with Pulmonary Arterial HypertensionD’Albini, L. / Tian, Y. / Raspa, S. / Drake, W. et al. | 2015
-
Socioeconomic Inequalities in Prenatal Care Utilization in pakistanJahangeer, R. A. et al. | 2015
-
Teriflunomide Shows Consistent Clinical Efficacy On Severe Relapses Across temso and tower: 2 Phase 3 trialsLeist, T. P. / Stangel, M. / Macdonell, R. / Mäurer, M. / Thangavelu, K. / Truffinet, P. / Bozzi, S. / Dive-Pouletty, C. / Freedman, M. S. et al. | 2015
-
Burden of Illness for Patients with familial amyloidotic Polyneuropathy (Fap) Begins Early and Increases with Disease ProgressionDenoncourt, R. N. / Adams, D. / Coelho, T. / Bettencourt, B. R. / Plaisted, A. / Amitay, O. / Falzone, R. / Harrop, J. / White, L. / De Frutos, R. et al. | 2015
-
Impact of Young-onset Parkinson’s Disease on Quality of Life €“ a Literature ReviewSosnowski, L. / Kamal, K. M. / Pawar, G. et al. | 2015
-
Specialty tier cost sharing and use of disease modifying Therapies Among Medicare Beneficiaries with Multiple SclerosisDoshi, J. A. / Li, P. / Yu, X. / Dahodwala, N. A. / Chahin, S. et al. | 2015
-
Evaluating trends in Chronic Pain prevalence in the United States veterans Health Administration PopulationLi, L. / Shrestha, S. / Baser, O. / Wang, L. et al. | 2015
-
The budget impact of treating Patients with Non-Diabetic Peripheral Neuropathic Pain (PNP) with capsaicin 8% patch for either Pregabalin-Naive or Pregabalin-Treated Patients in ScotlandPatel, S. / Chambers, C. / Garnham, A. et al. | 2015
-
Cost analysis of Voriconazole versus Caspofungin for Primary Therapy of invasive Aspergillosis among High-Risk Hematologic Cancer Patients in ChinaGao, X. / Xue, M. / Stephens, J. / Chen, Y. / Haider, S. / Charbonneau, C. et al. | 2015
-
Hydrocodone: a review of the LiteratureHatfield, M. D. / Fleming, M. L. et al. | 2015
-
Cost-effectiveness of Rituximab versus Calcineurin inhibitors for refractory Myasthenia GravisGeorgieva, M. / Wheeler, S. / Howard Jr., J. F. et al. | 2015
-
Forecasting the United States Lifetime Cost and outcomes of Ivacaftor in Patients with Cystic FibrosisDilokthornsakul, P. / Campbell, J. D. et al. | 2015
-
Patient-Reported Outcomes (PRO) in Patients with type 1 Myotonic Dystrophy type 1 – a systematic Literature reviewOgunsanya, M. / Kalb, S. / Yeh, W. et al. | 2015
-
Measurement properties of Web based Lupuspro, a disease targeted Otcome Tool, among Italian Patients with LupusJolly, M. / Mazzoni, D. / Cicognani, E. et al. | 2015
-
Major early complications following Bariatric Surgery: a systematic review and meta-analysisFreeman, N. L. / Stoll, C. R. / Carlsson, N. P. / Calhoun, A. J. / Eagon, J. C. / Colditz, G. A. / Chang, S. et al. | 2015
-
Trends in Approvals of New Drugs with Orphan Designation in the us (1983-2014)Alhawwashi, S. T. / Alshahrani, A. M. / Alsahali, S. M. / Alasmari, M. S. / Seoane-Vazquez, E. / Rodriguez-Monguio, R. / Szeinbach, S. L. et al. | 2015
-
Effect of Florida’s prescription monitoring Program and pill-mill Laws on Opioid prescribing and UtilizationDaubresse, M. / Rutkow, L. / Chang, H. / Stuart, E. / Webster, D. / Alexander, G. C. et al. | 2015
-
Treatment of Obesity: Pharmacotherapy trends in the United States from 1999 to 2010Xia, Y. / Kelton, C. M. / Heaton, P. C. / Guo, J. J. et al. | 2015
-
Editorial Board| 2015
-
Utilization of Antidiabetics After Fda Safety AnnouncementsDing, Y. / Gascue, L. / Lu, Y. / Ning, N. / Joyce, G. et al. | 2015
-
How Much Evidence Do We Need Before Implementing Pharmacogenomic Testing In The Clinic?Guzauskas, G. F. / Serbin, M. / Veenstra, D. L. et al. | 2015
-
Interventions For Ultra-Rare Disorders (Urds) And The Logic Of Cost EffectivenessSchlander, M. / Garattini, S. / Holm, S. / Kolominsky-Rabas, P. / Marshall, D. A. / Nord, E. / Persson, U. / Postma, M. / Richardson, J. / Simoens, S. et al. | 2015
-
Patient Preferences For First-Line Maintenance Treatments For Ovarian CancerMansfield, C. A. / Poulos, C. / Hackshaw, M. D. / Pugh, A. / Jobanputra, M. H. et al. | 2015
-
Development And Content Validity Of A Pediatric Functional Constipation Daily DiaryTurner-Bowker, D. M. / Lindner, E. / Mareya, S. / Losch-Beridon, T. / Elash, C. A. / Paty, J. / Keithly, S. / Ascoytia, C. et al. | 2015
-
Health-Related Quality Of Life Among Esrf Patients In Pakistan: A Cross-Sectional Approach Using Whoqol-BrefIqbal, M. Z. / Iqbal, M. S. / Iqbal, M. W. / Bahari, M. B. / Nasir, S. et al. | 2015
-
Pharmacoeconomics Education In Who Eastern Mediterranean RegionAl-Efan, Q. M. / Al-Emam, S. / Mukattash, T. L. / Mhaidat, N. M. / Al-Abbadi, I. / Rascati, K. et al. | 2015
-
Pace Continuous Innovation Indicators—A Novel Tool To Measure Progress In Cancer TreatmentsPaddock, S. / Brum, L. M. / Sorrow, K. / Thomas, S. / Spence, S. / Maulbecker-Armstrong, C. / Goodman, C. / Peake, M. / McVie, G. / Ramers-Verhoeven, C. et al. | 2015
-
Psychometric Validation Of The Fatigue Symptoms And Impacts Questionnaire–Relapsing Multiple Sclerosis (Fsiq-Rmsâ„¢)Hudgens, S. / Schüler, R. / Hunsche, E. / Leist, T. et al. | 2015
-
Resource Modelling: The Missing Piece of the HTA Jigsaw?Thokala, P. / Dixon, S. / Jahn, B. et al. | 2015
-
Rethinking Cost-Effectiveness In The Era Of Zero Healthcare Spending GrowthArbel, R. / Greenberg, D. et al. | 2015
-
Comparison of quantiferon TB-GOLD (QFT-GIT) test versus tuberculin skin test (TST) for latent tuberculosis infection (LTBI) screening among national guard general population in Saudi ArabiaEl Beltagy, K. et al. | 2015
-
Cardioverter-defibrillator: the choice between the need and limited resourcesGurtskaya, G. / Kulkhan, T. / Sasykova, A. / Issatayeva, N. et al. | 2015
-
Cost attributed to productivity loss in patients subjected to Pacemaker (PM) and Implantable Cardioverter-Defibrillator (ICD) implantationFanourgiakis, J. A. / Simantirakis, E. / Kanoupakis, E. / Chrysostomakis, S. / Maniadakis, N. / Kourlamba, G. / Vardas, P. et al. | 2015
-
Integrating big data to assess the economic impact of the implantable Cardioverter Defibrillator TherapyMadotto, F. / Conti, S. / Chiodini, V. / Mantovani, L. G. / Fornari, C. / Cesana, G. et al. | 2015
-
Is there utility in clinical utility modeling for Diagnostic Technologies?Hertz, D. / Taggart, C. / Waterman, J. / Armstrong, S. et al. | 2015
-
Long term follow up of Primary and Secondary prevention implantable cardioverter defibrillator patients: “Real-World” data from the Island of creteKanoupakis, E. / Fanourgiakis, J. A. / Mavrakis, H. / Kallergis, E. / Petousis, S. / Vernardos, M. / Chlouverakis, G. / Vardas, P. et al. | 2015
-
Efficacy and Safety of Insulin Analogues Compared to Human Insulin Preparations for the treatment of Patients With Diabetes Type 1 (Dm1): Systematic Review and Meta-AnalysisGuerra-Junior, A. a. / Araujo, V. E. / Izidoro, J. B. / Diniz, L. M. / Silva, M. R. / Mata, A. R. / Nascimento, R. C. / Alvares, J. / Acurcio, F. a. et al. | 2015
-
Anti-Diabetic Therapies and the risk of acute Pancreatitis: a Nationwide Retrospective cohort study from taiwanChiang, Y. / Chang, H. / Hsieh, C. / Singh, S. / Tang, W. / Tasi, Y. / Huang, W. et al. | 2015
-
Utilization of Negative Controls to Examine association between Rare Genetic Disorders and Type 2 Diabetes in four Large Observational DatabasesDesai, J. / Kabadi, S. / St. Louis, M. / Hyde, C. / Bonato, V. / Loomis, K. et al. | 2015
-
Impact of a Pharmacist telephone intervention on medication adherence among Hypertensive Patients with diabetes in a medicare advantage planAbughosh, S. / Wang, X. / Serna, O. / Henges, C. / Essien, E. / Masilamani, S. / Fleming, M. et al. | 2015
-
Current real-world prescribing patterns in type 2 diabetes mellitus: what comes after metformin? Evidence from u.s. Integrated delivery networksApfelbaum, L. / Iorga, S. R. / McDonald, M. / Liu, L. / Piper, B. A. / Sollano, J. et al. | 2015
-
Info-Diabetic approach from cellular phone Text massaging can Minimize the Complexities In diabetic Patient careKumar, N. / Gupta, B. K. / Dixit, V. K. / Pathak, P. / Sharma, V. P. et al. | 2015
-
Assessment of a french Endocrinologist electronic medical Record database for use In observational StudiesHellard, C. / Jouaville, S. / Pilet, S. / Meihoc, A. et al. | 2015
-
Does the ownership and use of Mosquito treated nets by household members depend on the level of Education of the head of household? case study of Western KenyaAlvin, M. M. / Mogere, D. M. et al. | 2015
-
Perceptions of the roles of Patients and Payers in Pharmaceutical Market AccessSendyona, S. / Choksi, P. / Odeyemi, I. A. / Toumi, M. et al. | 2015
-
Impact of 2014 essential Health benefit benchmark plans on us managed careAggarwal, S. / Topaloglu, H. et al. | 2015
-
The impact of new Drug pricing policy on market competition among off-patent Drugs in South KoreaKwon, H. / Kim, H. / R. Reich, M. et al. | 2015
-
An assessment of the Therapeutic Biologic products licensed by the FDA and the EMAGrozdanova, A. / Olasupo, O. / Seoane-Vazquez, E. et al. | 2015
-
Breakthrough Therapy status – expedited FDA regulatory approval but what about the payers?Macaulay, R. / Cost, P. et al. | 2015
-
The use of Pharmacy claims data as an early indicator of Bioequivalence issues for newly launched Generic MedicationsLevin, R. / Cosmatos, I. / Germscheid, L. M. / Frazee, S. / Dieck, G. / Murray, R. / Patel, A. / Henderson, R. et al. | 2015
-
The financial impact of Blood specimen rejection due to the poor pre-analytical Quality in Healthcare Facility in ChinaLiu, Y. / Ren, X. et al. | 2015
-
Comparative Effectiveness Research (CER) and its effect on the Health Care decision-making EnvironmentWestrich, K. D. et al. | 2015
-
Developing Hospital Based Hta For Egyptian Cancer PatientsAbo Taleb, A. M. / Saad, A. S. / Kamal, K. A. / Metry, A. B. et al. | 2015
-
Is spatial segregation by income associated with self-reported disability in chile? Exploratory analysis using a population-based surveyZitko, P. / Cabieses, B. et al. | 2015
-
Analysis Of Treatment Cost For Uterine Fibroids In UkrainePiniazhko, O. / Zalis’ka, O. / Vernikovskyy, I. / Gnatyshak, L. / Got, N. et al. | 2015
-
The Impact Of Parents’ Knowledge And Practice On Their Children Immunization Timeliness: Experience From MalaysiaAwadh, A. / Hassali, M. / Al-lela, O. / Bux, S. et al. | 2015
-
Sample Structure In A Prospective Study Of 22,000 Women Using Hormone Replacement Therapy (Hrt) Retained Unbiased After A Five-Year Follow-UpEichmann, F. / Klamert, A. / Potthoff, P. / Kanitscheider, C. et al. | 2015
-
The Value Adults Place On Child Health And Functional StatusCraig, B. / Brown, D. / Reeve, B. et al. | 2015
-
Health Related Quality Of Life In Patients Using Complementary Alternative Medicine (Homeopathy) In Quetta, Pakistanul Haq, N. / Akram, A. / Iqbal, Q. / Naseem, A. / Mohammd, S. / Ahmed, N. / Farooqui, M. et al. | 2015
-
Impact Of The Patient Protection And Affordable Care Act Contraceptive Coverage Mandate On Utilization Of Refillable And Long-Acting Reversible ContraceptivesVlahiotis, A. / Tian, Y. / Iyengar, R. et al. | 2015
-
Temporal Trend In Use Of Permanent Female Sterilization Procedures And Characteristics Of Women Who Undergo Them In A Commercially-Insured Population In The U.SCarney, P. / Lin, J. / Xia, F. / Law, A. et al. | 2015
-
Healthcare Utilization and costs of Serotonin Syndrome with concomitant use of Serotonergic agentsXie, L. / Wang, Z. / Alley, S. / Baser, O. / Nguyen, C. et al. | 2015
-
Systematic review with Qualitative Assessment of Antidepressant Monotherapies in Patients with Major depressive Disorder with an inadequate response to a prior SSRI or SNRIBrignone, M. / Painchault, C. / Diamand, F. et al. | 2015
-
Socio-Economic factors Associated with Pre-Natal Alcohol ingestion in Coastal Ghana: a cross-sectional study in 2014Da Pilma, J. L. / Davies-Teye, B. B. / Vanotoo, L. / Dako-Gyeke, P. et al. | 2015
-
Comparative analysis of Prescription Utilization and costs of Lurasidone and Aripiprazole: a Pharmacy-Database StudyNg-Mak, D. S. / Brook, R. A. / Rajagopalan, K. / Taitel, M. S. / Lou, Y. / Loebel, A. et al. | 2015
-
Estimating the cost-effectiveness of Vortioxetine versus Desvenlafaxine as first line Therapy for mild to moderate Major depressive Disorder in remitted patientsKeyloun, K. R. / Devine, B. et al. | 2015
-
A Review of Clinical outcome Assessments used in FDA approved Drug labels for Mental Health conditionsPompilus, F. A. / Lindberg-Springs, S. / Seoane-Vazquez, E. et al. | 2015
-
Can Social Network analysis be used to Identify Doctor Shoppers?Perry, B. / Freeman, P. R. / Oser, C. B. / Martel, M. M. / Talbert, J. et al. | 2015
-
Association Between Osteoarthritis and Workplace AbsenteeismMenon, J. / Thomas, I. J. et al. | 2015
-
Risk Of Diabetes With Or Without The Presence Of Other Obesity-Related Comorbidities (Hypertension, Stroke And Coronary Heart Disease): National Health And Nutrition Examination Survey, 2007-2010Leung, M. Y. / Carlsson, N. P. / Colditz, G. A. / Chang, S. et al. | 2015
-
Effectiveness And Cost-Effectiveness Of Catheter-Directed Thrombolysis In Massive Pulmonary EmbolismKostyuk, A. / Akanov, A. / Garkalov, K. et al. | 2015
-
Mipomersen For Treatment Of Hypercholesteremia: Evidence Review And Meta Analytic Evaluation Of Randomized Controlled TrialsBardia, A. / Garg, G. et al. | 2015
-
The Association Between Choice Of Balanced Intravenous Crystalloid And Subsequent Major In-Hospital Outcomes Among Adult Patients Undergoing Cardiac SurgeryRaghunathan, K. / Khangulov, V. S. / Peyerl, F. W. / Shaw, A. D. et al. | 2015
-
Increased Risk Of Arrhythmia In Patients With Psoriasis: A Matched Cohort StudyChang, W. / Chiu, H. / Huang, W. / Wen, Y. / Tsai, Y. / Tsai, T. et al. | 2015
-
Estimating The Cost Of Illness Of Giant Cell ArteritisBabigumira, J. B. / Li, M. / Boudreau, D. M. / Best, J. H. / Garrison, L. P. et al. | 2015
-
Cost-Utility Analysis of Apixaban In Patients With Atrial Fibrillation (Af) At The Peruvian Social Security (Essalud)Sanabria, C. / Cabrejos, J. / Garrido Lecca, S. / Olortegui, A. / Guevara, C. et al. | 2015
-
Compliance And Control Of Hypertension With Co-Morbidities In Primary Care In UkraineKorzh, O. et al. | 2015
-
bisphosphonates for fracture prevention in males – a systematic review and meta-analysisCheng, Y. / Jiao, T. / Willson, T. / Reese, T. / Stoddard, G. J. / LaFleur, J. et al. | 2015
-
Health care cost burden and demographic distribution of patients diagnosed with psoriatic arthritis in the u.s. Medicare populationLi, L. / Mao, X. / Shrestha, S. / Baser, O. / Yuce, H. / Wang, L. et al. | 2015
-
A Systematic Literature Review of The Cost-Effectiveness of Erythropoietin In Orthopedic Surgery: There Is A Need For Differentiation Between Total Hip And Knee ArthroplastyDegener, F. / Postma, M. J. et al. | 2015
-
Cost-Effectiveness of Tocilizumab for The Management of Inadequately Responding Rheumatoid Arthritis PatientsHansen, R. N. / Best, J. H. / Sullivan, S. D. / Carlson, J. J. et al. | 2015
-
Cost-Effectiveness Analysis of Condoliase In Patients With Lumbar Disc Herniation In JapanIkeda, S. / Inoue, S. / Kobayashi, M. et al. | 2015
-
Meta-Analysis of Efficacy and Safety of Denosumab In Postmenopausal OsteoporosisXuan, S. / Ma, J. / Liu, G. G. et al. | 2015
-
Socio-Economic Status and Work Disability Among Patients With Rheumatic Diseases In the Slovak RepublicTomek, D. / Hroncova, D. / Pechac, P. et al. | 2015
-
Relationship Between Physician Assessment of Disease Severity (Per Clinical Judgment) and Objective Measures of Disease Severity In Rheumatoid Arthritis (RA): Observations From The European Union (EU) And United States (US)Narayanan, S. / Lu, Y. / Hutchings, R. / Baskett, A. et al. | 2015
-
A descriptive analysis of patient characteristics and health care burden associated with chronic obstructive pulmonary disease in the u.s. Medicare populationXie, L. / Kariburyo, M. F. / Wang, Y. / Baser, O. et al. | 2015
-
Improved Health Care outcomes and Cost Savings for Asthma Through Targeted Home InterventionsNorlien, K. G. / Carlson, A. M. / York, P. V. et al. | 2015
-
Drug Therapy for Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review And Network Meta-AnalysisCanestaro, W. J. / Forrester, S. / Ho, L. / Devine, B. et al. | 2015